EP0861021A1 - Gene modifie de bacillus thuringiensis pour combattre les lepidopteres sur les plantes - Google Patents
Gene modifie de bacillus thuringiensis pour combattre les lepidopteres sur les plantesInfo
- Publication number
- EP0861021A1 EP0861021A1 EP96936576A EP96936576A EP0861021A1 EP 0861021 A1 EP0861021 A1 EP 0861021A1 EP 96936576 A EP96936576 A EP 96936576A EP 96936576 A EP96936576 A EP 96936576A EP 0861021 A1 EP0861021 A1 EP 0861021A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sequence
- gene
- plant
- maize
- icp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 303
- 241000193388 Bacillus thuringiensis Species 0.000 title claims abstract description 11
- 229940097012 bacillus thuringiensis Drugs 0.000 title claims abstract description 10
- 241000196324 Embryophyta Species 0.000 claims abstract description 160
- 240000008042 Zea mays Species 0.000 claims abstract description 126
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 122
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims abstract description 121
- 235000009973 maize Nutrition 0.000 claims abstract description 121
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 76
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 54
- 230000014509 gene expression Effects 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 36
- 230000000749 insecticidal effect Effects 0.000 claims abstract description 29
- 108020004705 Codon Proteins 0.000 claims description 185
- 239000002773 nucleotide Substances 0.000 claims description 126
- 125000003729 nucleotide group Chemical group 0.000 claims description 126
- 230000009261 transgenic effect Effects 0.000 claims description 38
- 108700010070 Codon Usage Proteins 0.000 claims description 32
- 108091026890 Coding region Proteins 0.000 claims description 25
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 108700005078 Synthetic Genes Proteins 0.000 claims description 16
- 239000013598 vector Substances 0.000 claims description 14
- 101710151559 Crystal protein Proteins 0.000 claims description 13
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 230000002068 genetic effect Effects 0.000 claims description 12
- 238000013518 transcription Methods 0.000 claims description 11
- 230000035897 transcription Effects 0.000 claims description 11
- 230000008488 polyadenylation Effects 0.000 claims description 10
- 230000002441 reversible effect Effects 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 7
- 108700028146 Genetic Enhancer Elements Proteins 0.000 claims description 6
- 241001233957 eudicotyledons Species 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 5
- 102000039446 nucleic acids Human genes 0.000 claims description 5
- 235000007319 Avena orientalis Nutrition 0.000 claims description 4
- 244000075850 Avena orientalis Species 0.000 claims description 4
- 241000209510 Liliopsida Species 0.000 claims description 4
- 244000062793 Sorghum vulgare Species 0.000 claims description 4
- 239000003623 enhancer Substances 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 231100000765 toxin Toxicity 0.000 claims description 3
- 244000105624 Arachis hypogaea Species 0.000 claims description 2
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 2
- 240000002791 Brassica napus Species 0.000 claims description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 244000299507 Gossypium hirsutum Species 0.000 claims description 2
- 244000020551 Helianthus annuus Species 0.000 claims description 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 241000209504 Poaceae Species 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 2
- 235000007238 Secale cereale Nutrition 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 2
- 235000021536 Sugar beet Nutrition 0.000 claims description 2
- 244000223014 Syzygium aromaticum Species 0.000 claims description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- 235000021374 legumes Nutrition 0.000 claims description 2
- 235000019713 millet Nutrition 0.000 claims description 2
- 235000020232 peanut Nutrition 0.000 claims description 2
- 235000012015 potatoes Nutrition 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 230000002123 temporal effect Effects 0.000 claims description 2
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 claims 1
- 101150021974 Adh1 gene Proteins 0.000 claims 1
- 241000209056 Secale Species 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 abstract description 17
- 230000002588 toxic effect Effects 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 239000013612 plasmid Substances 0.000 description 128
- 108020004414 DNA Proteins 0.000 description 125
- 239000012634 fragment Substances 0.000 description 118
- 235000018102 proteins Nutrition 0.000 description 68
- 108091034117 Oligonucleotide Proteins 0.000 description 64
- 210000004027 cell Anatomy 0.000 description 57
- 241000588724 Escherichia coli Species 0.000 description 50
- 239000002253 acid Substances 0.000 description 42
- 210000001519 tissue Anatomy 0.000 description 41
- 241000702489 Maize streak virus Species 0.000 description 40
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 39
- 239000000499 gel Substances 0.000 description 38
- 206010020649 Hyperkeratosis Diseases 0.000 description 36
- 238000003786 synthesis reaction Methods 0.000 description 29
- 241000701489 Cauliflower mosaic virus Species 0.000 description 27
- 230000015572 biosynthetic process Effects 0.000 description 27
- 210000001938 protoplast Anatomy 0.000 description 26
- 239000002609 medium Substances 0.000 description 23
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 22
- 150000007513 acids Chemical class 0.000 description 22
- 108091008146 restriction endonucleases Proteins 0.000 description 22
- 230000009466 transformation Effects 0.000 description 19
- 230000029087 digestion Effects 0.000 description 17
- 239000000284 extract Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 229940088598 enzyme Drugs 0.000 description 15
- 108020004999 messenger RNA Proteins 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 238000006467 substitution reaction Methods 0.000 description 15
- 108700026244 Open Reading Frames Proteins 0.000 description 14
- 239000008188 pellet Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 238000013461 design Methods 0.000 description 12
- 239000013604 expression vector Substances 0.000 description 12
- 238000007792 addition Methods 0.000 description 11
- 239000011543 agarose gel Substances 0.000 description 11
- 238000003556 assay Methods 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 210000002257 embryonic structure Anatomy 0.000 description 11
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 11
- 239000010931 gold Substances 0.000 description 11
- 229910052737 gold Inorganic materials 0.000 description 11
- 238000013507 mapping Methods 0.000 description 11
- 230000000295 complement effect Effects 0.000 description 10
- 230000001086 cytosolic effect Effects 0.000 description 10
- 239000003550 marker Substances 0.000 description 10
- 101710115267 ATP synthase protein MI25 Proteins 0.000 description 9
- 238000000137 annealing Methods 0.000 description 9
- 238000010276 construction Methods 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000007858 starting material Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 108060001084 Luciferase Proteins 0.000 description 8
- 238000012300 Sequence Analysis Methods 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000004520 electroporation Methods 0.000 description 8
- 239000001307 helium Substances 0.000 description 8
- 229910052734 helium Inorganic materials 0.000 description 8
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 8
- 230000008929 regeneration Effects 0.000 description 8
- 238000011069 regeneration method Methods 0.000 description 8
- 238000013519 translation Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 7
- 239000005089 Luciferase Substances 0.000 description 7
- 238000012937 correction Methods 0.000 description 7
- 230000000977 initiatory effect Effects 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 206010061217 Infestation Diseases 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- 108091081024 Start codon Proteins 0.000 description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000005422 blasting Methods 0.000 description 6
- 238000012217 deletion Methods 0.000 description 6
- 230000037430 deletion Effects 0.000 description 6
- 230000000408 embryogenic effect Effects 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 238000012423 maintenance Methods 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000010561 standard procedure Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 101710132601 Capsid protein Proteins 0.000 description 5
- 101710094648 Coat protein Proteins 0.000 description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 5
- 101000856513 Homo sapiens Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Proteins 0.000 description 5
- 102100025509 Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Human genes 0.000 description 5
- 101710125418 Major capsid protein Proteins 0.000 description 5
- 241000255908 Manduca sexta Species 0.000 description 5
- 101710141454 Nucleoprotein Proteins 0.000 description 5
- 101710083689 Probable capsid protein Proteins 0.000 description 5
- 108700008625 Reporter Genes Proteins 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 108700001094 Plant Genes Proteins 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 239000007984 Tris EDTA buffer Substances 0.000 description 4
- 101150103518 bar gene Proteins 0.000 description 4
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 101150054900 gus gene Proteins 0.000 description 4
- 239000004009 herbicide Substances 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 239000013600 plasmid vector Substances 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 235000013930 proline Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 108091033380 Coding strand Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 3
- 229920002148 Gellan gum Polymers 0.000 description 3
- 108010060309 Glucuronidase Proteins 0.000 description 3
- 102000053187 Glucuronidase Human genes 0.000 description 3
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 3
- 241001147381 Helicoverpa armigera Species 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 101150010882 S gene Proteins 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000004166 bioassay Methods 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000009585 enzyme analysis Methods 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 230000037433 frameshift Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000002363 herbicidal effect Effects 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 101150066555 lacZ gene Proteins 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 230000000392 somatic effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- NLIVDORGVGAOOJ-MAHBNPEESA-M xylene cyanol Chemical compound [Na+].C1=C(C)C(NCC)=CC=C1C(\C=1C(=CC(OS([O-])=O)=CC=1)OS([O-])=O)=C\1C=C(C)\C(=[NH+]/CC)\C=C/1 NLIVDORGVGAOOJ-MAHBNPEESA-M 0.000 description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 2
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 241000024188 Andala Species 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 108090000331 Firefly luciferases Proteins 0.000 description 2
- 241000256244 Heliothis virescens Species 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 2
- VPZKQTYZIVOJDV-LMVFSUKVSA-N Thr-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(O)=O VPZKQTYZIVOJDV-LMVFSUKVSA-N 0.000 description 2
- HYLXOQURIOCKIH-VQVTYTSYSA-N Thr-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N HYLXOQURIOCKIH-VQVTYTSYSA-N 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- WCDYMMVGBZNUGB-ORPFKJIMSA-N [(2r,3r,4s,5r,6r)-6-[[(1r,3r,4r,5r,6r)-4,5-dihydroxy-2,7-dioxabicyclo[4.2.0]octan-3-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3-hydroxy-2-tetradecyloctadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](COC(=O)C(CCCCCCCCCCCCCC)C(O)CCCCCCCCCCCCCCC)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H]2OC[C@H]2O1 WCDYMMVGBZNUGB-ORPFKJIMSA-N 0.000 description 2
- 230000001594 aberrant effect Effects 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 102000005421 acetyltransferase Human genes 0.000 description 2
- 108020002494 acetyltransferase Proteins 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000010307 cell transformation Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229920001940 conductive polymer Polymers 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000011491 glass wool Substances 0.000 description 2
- 230000001744 histochemical effect Effects 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000009616 inductively coupled plasma Methods 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 238000002515 oligonucleotide synthesis Methods 0.000 description 2
- 150000002972 pentoses Chemical class 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000010152 pollination Effects 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- UDYXMTORTDACTG-UHFFFAOYSA-N 1,1,3-tributylthiourea Chemical compound CCCCNC(=S)N(CCCC)CCCC UDYXMTORTDACTG-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- KDELTXNPUXUBMU-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid boric acid Chemical compound OB(O)O.OB(O)O.OB(O)O.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KDELTXNPUXUBMU-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- ARQXEQLMMNGFDU-JHZZJYKESA-N 4-methylumbelliferone beta-D-glucuronide Chemical compound C1=CC=2C(C)=CC(=O)OC=2C=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ARQXEQLMMNGFDU-JHZZJYKESA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- CXRCVCURMBFFOL-FXQIFTODSA-N Ala-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 101710187578 Alcohol dehydrogenase 1 Proteins 0.000 description 1
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 1
- WVRUNFYJIHNFKD-WDSKDSINSA-N Arg-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N WVRUNFYJIHNFKD-WDSKDSINSA-N 0.000 description 1
- XNSKSTRGQIPTSE-ACZMJKKPSA-N Arg-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O XNSKSTRGQIPTSE-ACZMJKKPSA-N 0.000 description 1
- XTWSWDJMIKUJDQ-RYUDHWBXSA-N Arg-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XTWSWDJMIKUJDQ-RYUDHWBXSA-N 0.000 description 1
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 1
- NVPHRWNWTKYIST-BPNCWPANSA-N Arg-Tyr-Ala Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 NVPHRWNWTKYIST-BPNCWPANSA-N 0.000 description 1
- QMQZYILAWUOLPV-JYJNAYRXSA-N Arg-Tyr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CC1=CC=C(O)C=C1 QMQZYILAWUOLPV-JYJNAYRXSA-N 0.000 description 1
- 101100462166 Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) omtB gene Proteins 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- NDUPDOJHUQKPAG-UHFFFAOYSA-N Dalapon Chemical compound CC(Cl)(Cl)C(O)=O NDUPDOJHUQKPAG-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 241000237537 Ensis Species 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- -1 FOD phosphoramidites Chemical class 0.000 description 1
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 241000255967 Helicoverpa zea Species 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
- 101710192606 Latent membrane protein 2 Proteins 0.000 description 1
- 241000984622 Leucodon Species 0.000 description 1
- 241000256010 Manduca Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 101710202365 Napin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 101710089395 Oleosin Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102000039471 Small Nuclear RNA Human genes 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 108700026226 TATA Box Proteins 0.000 description 1
- 101710109576 Terminal protein Proteins 0.000 description 1
- 241000030538 Thecla Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- MFEVVAXTBZELLL-GGVZMXCHSA-N Tyr-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MFEVVAXTBZELLL-GGVZMXCHSA-N 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 101710134973 Uncharacterized 9.7 kDa protein in cox-rep intergenic region Proteins 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 241000209149 Zea Species 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000021405 artificial diet Nutrition 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229940089639 cornsilk Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000032459 dedifferentiation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 229940023064 escherichia coli Drugs 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 238000007421 fluorometric assay Methods 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 230000009571 larval growth Effects 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 150000003148 prolines Chemical group 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229920006298 saran Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 108091029842 small nuclear ribonucleic acid Proteins 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- RWVGQQGBQSJDQV-UHFFFAOYSA-M sodium;3-[[4-[(e)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-n-ethyl-3-methylanilino]methyl]benzenesulfonate Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=C1 RWVGQQGBQSJDQV-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 101150101900 uidA gene Proteins 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000001231 zea mays silk Substances 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the present invention relates to the design, synthesis and expression m plants of a DNA sequence that encodes a Bacill us thu ⁇ ngi ensis protein that is toxic to specific insects. More particularly, the invention is directed to a synthetic DNA sequence which is optimized for expression m plants, a vector containing the synthetic DNA sequence which is suitable for transforming plants, and plants which stably express the protein coded for by the synthetic DNA sequence.
- a widely used microbial pesticide is derived from the soil microbe Bacill us thurmgi ensi s ( Bt ) .
- Bt is a gram-positive, spore-forming bacterium characterized by parasporal crystalline protein inclusions.
- the crystal protein often referred to as the ⁇ -endotoxm, has two forms: a nontoxic protoxm with an approximate molecular weight (MW) of 130 ilodaltons (kD) ; and a toxic form having an approximate MW of 68 kD.
- the crystalline protein inclusions contain the protoxm protein which is activated in the gut of larvae of a number of insect species.
- the protoxm is cleaved, the toxic moiety residing in an ammo-proximal 58-68 kD polypeptide.
- the crystal is activated by being solubilized and converted to toxic form by the alkalinity and proteases of the insect gut.
- the toxic activity of the protein produced by Bt is highly specific to particular insect species and is recognized as safe to higher vertebrates. Numerous reports have shown that the mtrasporal crystal proteins isolated from many strains of Bt possess extremely high levels cf toxicity specific for Lepidopteran larvae, oi Coleopteran larvae, with an efrective concentration required to inhibit 50° o of larval growth in the range ol 1 ng/ l of diet for the most sensitive insects (Macintosh et al., J. Invert. Pathol. 565 (1990) 258) .
- codon usage may influence the expression of genes at the level of translation, transcription or mRNA processing.
- Another possible reason for low levels of expression of the native Bt gene in transgenic plants may be due to fortuitous transcription processing sites which produce aberrant forms of mRNA (International Publication No. WO 93/07278) .
- Possible processing sites include polyadenylation sites, mtron splicing sites, transcriptional termination signals and transport signals. Fortuitous occurrence of such processing sites in a coding region may complicate the expression of a gene a transgenic host.
- the synthetic gene is at least approximately 85° homologous to a native insecticidal protein gene of Bt and is designed such that its distribution frequency of codon usage deviates no more than 25% of highly expressed plant genes, and preferably no more than about 10..
- the synthetic gene has GC and TA doublet avoidance indices, based on the frequency a host gene sequence, that deviates from that of the host plant by no more than about 10-15°, and has a GC content of about 45°o.
- WO 93/07278 describes a synthetic Bt crystal protein gene in which codon usage has been altered in order to increase expression in maize.
- the synthetic gene is at least approximately 66. homologous to a native insecticidal protein gene of Bt and 98% homologous to a pure maize optimized gene.
- the synthetic gene has a GC content of from 50-64% and does not have prolmes at the 3' end of the sequence.
- the present invention is directed to the design, synthesis, and expression m both bacterial ana plant cells of a plant optimized DNA sequence that encodes a Bacill us thu ⁇ ngi ensi s HD73 protein which is toxic to Lepidopteran insects.
- the invention is further related to a method of designing a synthetic gene.
- plant optimized DNA sequence comprises codons effective to encocte an insecticidal plant protein (hereinafter ICP with about 589 to about 619 am o acids.
- the nucleotide sequence coding for ICP is about 70 to aoout 71% homologous to a native Bt nucleotide sequence encoding ICP, and about 63% homologous to a pure maize nucleotide sequence. Codon usage m the plant optimized nucleotide sequence has a deviation from that of the host plant of about 0.23 to about 3.48, preferably about 1.075.
- the present invention is also directed to plant expression vectors capable of expression m plant cells, such as maize.
- the plant expression vector comprising m sequence 5' to 3 ' , a promoter sequence effective to initiate transcription m plant cells; a translational enhancer sequence specific to maize; a first vector unique restriction enzyme cleavage site; a coding sequence coding for a protein typically of less than about 620 ammo acids, the protein preferably being substantially homologous with the ammo-proximal portion of a Bt ICP; a second vector unique restriction enzyme cleavage site; and a polyadenylation sequence.
- Another aspect of the invention is directed to a transgenic plant and seeds from a transgenic plant.
- This Bt synthetic gene is expressed in the cells of the plant or a plant grown from the seeds of the transgenic plant, m sufficient amounts to control lepidopteran insects.
- the present invention also provides methods of engineering any structural gene so that it may be optimally expressed m plants, m particular maize. Due to the plasticity afforded by the redundancy of the genetic code (i.e. some ammo acids are specified by more than one codoni the invention prescribes a method or modifying the genetic sequence of any gene so that the resulting protein that is expressed is unchanged, out tne codons are modified to optimize the expression of tne protein m the particular plant of interest.
- the codon bias of the plant is determined.
- the codon bias is the statistical codon distribution that the plant uses for coding its proteins.
- the percent frequency of the codons m the gene of interest such as a native Bacill us th uri ngi ensi s, is determined.
- the ammo acid sequence of the protein of interest is reverse translated so that the resulting nucleic acid sequence codes for the same protein as the native gene, but the resulting nucleic acid sequence corresponds to the first preferred codons of the desired plant.
- the new sequence is analyzed for restriction enzyme sites that might have been created by the modification. The identified sites are further modified by replacing the codons with second or third choice preferred codons.
- sequences which could affect the transcription or translation of the gene of interest are the exon.mtron 5' or 3' junctions, poly A addition signals, or RNA polymerase termination signals.
- the sequence is further analyzed and modified to reduce the frequency of TA or GC doublets.
- G or C sequence blocks that have more than about four residues that are the same can affect transcription of the sequence. Therefore, these blocks are also modified by replacing the codons of first or second choice, etc. with the next preferred codon of choice.
- the method described above enables one skilled m the art to modify gene(s) that are foreign to a particular plant so that the genes are optimally expressed m plants.
- the invention further provides a doubly enhanced 35S or 19S promoter which expresses foreign proteins, including Bt crystal protein or Bt insecticidal crystal proteins more effectively than a 35S or 19S promoter as well as a MSV leader sequence that could be further modified for use with other promoters.
- the invention provides a leader sequence which could be used to enhance the expression of any promoter.
- Fig. 1 illustrates the PCR synthesis strategy.
- Fig. 1A is a graphic representation of the modified ICP gene with key restriction sites indicated above the bar, numbers underneath denote their locations in the gene. The three gene parts that were synthesized separately are shown underneath the gene, the cloning sites incorporated into the ends of each part are shown at the ends of each fragment.
- Fig. IB sets forth the PCR synthesis of the 5' end fragment of the ICP gene. The 12 oligonucleotides used m the synthesis are indicated by arrows. The direction of the arrows correspond to the polarity of synthesis of the nascent DNA strand.
- each oligonucleotide m the gene fragment is indicated between the parentheses, the reverse order of the nucleotide location of the bottom set of oligonucleotides indicates their reverse complementarity to the top (coding) strand of the gene.
- Fig. 2 shows the resulting gel from tne purification of ICP oligonucleotides by denaturing PAGE.
- ICP oliqonucleotides Bt ⁇ through BtlO were fractionated by electrophoresis on 12% denaturing PAGE as described m Example 1. Oligonucleotide identities are shown above each lane, and the size of each (nucleotides) is shown below the lane.
- the mobilities of the trac inq dyes xylene cyanol (XC) and bromophenol blue (BPB) are indicated on the right.
- Fig. 3 shows a gel which illustrates the progression m the synthesis of the three ICP gene parts.
- products of PCR steps 1-6 (5' and 3' sections) or 1-5 (center section) are shown the lanes marked 1-6 or 1-5, respectively.
- Each lane contains 5 ⁇ l of gel purified DNA from the previous PCR step.
- Unmarked lanes at the outside of the gel contain 100 bp ladder DNA size standards (GIBCO/BRL) .
- Fig. 4 shows a gel that illustrates the expression of ICP in E. coll .
- ICP expressed in E. coll cells from a cytoplasmic expression vector was analyzed by SDS-PAGE and Western blotting as described m Example 4.
- Lane 1 contains an amount of E. coli total cell protein corresponding to about a 50 ng pellet of protein extract of E. coli cells expressing the cytoplasmic expression vector;
- lane 2 contains aoout 50 ng of cytoplasmic expression vector extract pellet;
- lane 3 contains about 10 ng of pellet extract.
- the negative control lane 4 contains 100 ng of extract pellet of E. coli cells expressing pET-9d.
- Lanes 5, 6 and 7 contain 20, 50 and 100 ng, respectively, of purified native Bt ICP.
- FIG. 5 is a graphical representation which sets forth the results of Manduca sexta bioassays. Feeding assays with 500 ng each of E . col i extract protein (pET- 9d pellet), pellet protein from extract of cells containing the ICP cytoplasmic expression plasmid cytoplasmic expression vector (CEV pellet) , cytoplasmic expression vector expressing cells (CEV cells) , and native ICP (Bt protein) were carried out as described in Example 6. Larval weight and mortality were scored 4 days after placing neonate larvae on the diets.
- pET- 9d pellet pellet protein from extract of cells containing the ICP cytoplasmic expression plasmid cytoplasmic expression vector
- CEV cells cytoplasmic expression vector expressing cells
- Bt protein native ICP
- Fig. 6 is a map of plasmid vector pDAB 910 as further described in Example 7.
- Fig. 7 is a map of plasmid vector pDAB 911 as further described m Example 7.
- Fig. 8 is a map of plasmid vector pDAB 917 as further described in Example 7.
- Fig. 9 is a gel that illustrates the expression of ICP m transgenic MSD callus.
- ICP expressed m MSD callus isolates was detected by SDS-PAGE and western blotting as described m Example 8.
- Lanes 1 through 7 contain callus extracts of maize isolates obtained by transformation of MSD line #4 with plasmid pDAB 911;
- lane 8 contains callus extract of nontransformed MSD line #4;
- lanes 9 and 10 contain 10 and 1 ng, respectively, of purified ICP.
- Fig. 10 is a map of plasmid vector pDAB303 as further described m Example 7.
- Fig. 11 illustrates several maps of tested promoters in plasmids pKA882, PDAB305, pDAB310, pDAB348 and pDAB353. More specifically, pKA882 contains the native 35S promoter, as embodied within CaMV nts 6605 to " 39 (MCASTRAS), followed by Linker Sequence A (SEQ. II .
- pDAB348 contains an enhanced 35S promoter with additional 3' sequences and embodied as nucleotides 7093 to 7344 of CaMV DNA, the linker sequence CATCGATG, nucleotides 7093 to 7439 of CaMV, followed by the Linker Sequence A from above.
- pDAB305 contains an enhanced 35S promoter witn additional 3' sequences and embodied as nucleotides 7093 to 7344 of CaMV DNA, the linker sequence CATCGATG, nucleotides 7093 to 7439 of CaMV, the linker sequence GGGGACTCTAGAGGATCCAG (SEQ. ID. NO. 4;, nucleotides 167 to 186 of MSV, nucleotides 188 to 277 of MSV, a C residue followed by nucleotides 120 to 210 of maize Adhl.S, nucleotides 555 to 672 of maize Adhl.S, the linker sequence GACGGATCTG (SEQ. ID. NO.
- pDAB310 contains an enhanced 35S promoter with additional 3' sequences and embodied as nucleotides 7093 to 7344 of CaMV DNA, the linker sequence CATCGATG, nucleotides 7093 to 7439 of CaMV, the linker sequence GGGGACTCTAGAGGATCCAG (SEQ. ID.
- nucleotides 167 to 186 of MSV nucleotides 188 to 317 of MSV, and a G residue that represents the final base of an Nco I recognition sequence, CCATGG.
- the GUS translational start codon is part of the Nco I site.
- Transcripts from this promoter contain the 5' untranslated leader essentially the MSV coat proteir leader sequence.
- pDAB353 contains an enhanced 35S promoter itn additional 3' sequences and embodied as nucleotides " 09° to 7344 of CaMV DNA, the linker sequence CATCGATG, nucleotides 7093 to 7439 of CaMV, the linker sequence GGGGACTCTAGAG (SEQ. ID. NO.
- nucleotides 120 to 210 of maize Adhl.S nucleotides 555 to 672 of maize Adhl.S, and the sequence CCGTCGACCATGG (SEQ. ID. NO. 8) .
- the GUS translational start codon is part of the Nco I site.
- Transcripts from this promoter contain as tne 5' untranslated leader essentially a deleted version of the maize Adh.S mtron 1.
- Crystal protein or insecticidal crystal protein (ICP) or crystal toxin refers to the major protein component of the parasporal crystals formed m strains of Bt . This protein component exhibits selective toxicity to different species of insects.
- the molecular size of the major protein isolated from parasporal crystals varies depending on the strain of Bt from which it is derived. Crystal proteins having molecular weights of approximately 132, 65, and 28 kDa have oeen reporter. It has oeen shown that the approximately 132 kDa prote_- is a protoxm that is cleaved to form an ammo prox ⁇ ma_ msect toxm of approximately 65 kDa.
- the crystal protei n gene refers to the DNA sequence encoding the insecticidal crystal protein in either full lenqth protoxm or toxm form, depend q on the strain of Bt from which the gene is derived.
- nucl eoti de refers to monomeric unit of DNA or RNA consisting of a sugar moiety (pentose) , a phosphate, and a nitrogenous heterocyclic base.
- the base is linked to the sugar moiety via the glycosidic carbon (1' carbon of the pentose) .
- the combination of base and sugar is called a nucleosi ⁇ e; the base characterizes the nucleotide.
- the rour DNA bases are adenme ("A"), guamne ("G”), cytosine ("C”), and thym e ("T”) .
- the four RNA bases are A, G, C, and uracil (“U”) .
- a structural gene is that portion of a gene comprising a DNA segment encoding a protein, polypeptide or a portion thereof, and excluding the 5' sequence which drives the initiation of transcription.
- the structural gene may be one which is normally found in the cell or one which is not normally found in the cellular location wherein it is introduced, in which case it is termed a heterol ogous gene .
- a heterologous gene may be derived whole or m part from any source known to the art, including a bacterial genome or episome, eukaryotic, nuclear or plasmid DNA, cDNA, viral DNA or cnemically synthesized DNA.
- a structural gene may contain one or more modifications either the coding or the untranslated regions which could affect the biological activity or the chemical structure of the expression product, the rate of expression or the manner of expression control. Such modifications include, but are not limited to, mutations, insertions, deletions and substitutions of one or more nucleotides.
- the structural gene ma ⁇ constitute an uninterrupted coding sequence or it may include one or more nitrons, bounded by the appropriate splice junctions.
- the structural gene a ⁇ be a composite of segments derived from a plurality of sources (naturally occurring or synthetic, where synthetic refers to DNA that is chemically synthesized) .
- the structural gene may also encode a fusion protein.
- Operably linked refers to a juxtaposition wherein the components are configured so as to perform their usual function.
- control sequences operably linked to a coding sequence are capable of effecting the expression of the coding sequence.
- Plant ti ssue includes differentiated and undifferentiated tissues of plants, including, but not limited to, roots, shoots, leaves, pollen, seeds, tumor tissue and various forms of cells in culture, such as single cells, protoplasts, embryos and callus tissue.
- the plant tissue may be in planta or m organ, tissue or cell culture.
- Plant cell as used herein includes plant cells in planta and plant cells and protoplasts m culture.
- Homol ogy refers to identity or near identity of nucleotide or amino acid sequences.
- nucleotide mismatches can occur at the third or wobble base in the codon without causing ammo acid substitutions the final polypeptide sequence.
- minor nucleotide modifications e.g., substitutions, insertions or deletions
- certain regions of the gene sequence can be tolerated whenever such modifications result m changes m am o acid sequence that do not alter functionality of the final product. It has been shown that chemically synthesized copies of whole, or parts of, gene sequences can replace the corresponding regions m the natural gene without loss of gene function.
- Homologs of specific DNA sequences may be identified by those skilled in the art using the test cf cross-hybridization of nucleic acids under conditions of stringency as is well understood m the art (as described in Hames et al. , Nucleic Acid Hybridisation, (1985) IRL Press, Oxford, UK) . Extent of homology is often measured terms of percentage of identity between the sequences compared.
- Preferred codon or freguency of preferred codon usage refers to the preference exhibited by a specific host cell usage of nucleotide codons to specify a given ammo acid. To determine the frequency of usage of a particular codon m a gene, the number of occurrences of that codon in the gene is divided by the total number of occurrences of all codons specifying the same ammo acid the gene. The frequency of preferred codon usage exhibited by a host cell can be calculated by averaging the frequency of preferred codon usage m a large number of genes expressed by the host cell.
- the percent deviation of the frequency of preferred codon usage for a synthetic gene from that employed by a host cell is calculated first by determining the percent deviation of the frequency of usage of a single codon from that of the host cell followed by obtaining the average deviation over all codons. As defined herein, this calculation includes unique codons (i.e., ATG and TGG) . In general terms the overall average deviation of the codon usage of a synthetic gene from that of a host cell is calculated using the equation - X 100
- X frequency of usage for codon n the host cell
- Y frequency of usage for codon n m the synthetic gene
- n represents an individual codon that specifies an ammo aci ⁇
- wnere the total number or codons is Z.
- pure plan t optimi zed nucl eoti de sequence refers to a gene or DNA sequence comprising 100% of the host plant preferred codon sequences for a particular polypeptide.
- a pure mai ze optimi zed sequence is a gene or DNA sequence which comprises 100% of the maize preferred codon sequence for a particular polypeptide.
- a pl ant optimi zed nucl eo ti de sequence refers to a gene or DNA sequence produced from variations of the pure plant optimized sequence.
- the variations as described herein include alterations of the pure plant optimized nucleotide sequence to permit manipulation of the gene, such as by altering a nucleotide to create or eliminate restriction sites; and variations to eliminate potentially deleterious processing sites, such as potential polyadenylation sites or intron splicing recognition sites.
- a mai ze optimi zed nucl eotide sequence refers to a gene or DNA sequence produced from variations of a pure maize optimized sequence.
- Deri ved from is used to mean taken, obtained, received, traced, replicated or descended from a source (chemical and/or biological) .
- a derivative may be produced by chemical or biological manipulation (including, but not limited to, substitution, addition, insertion, deletion, extraction, isolation, mutatior and replication) of the original source.
- Cnemi cally synthesi zed, as related to a sequence of DNA, means that the component nucleotides were assemoled in vitro.
- desi gned to be highly expressed refers to a level of expression of a designed gene wherein the amount of its full-length specific mRNA transcripts produced is sufficient to be quantified m Northern blots and, thus, represents a level of specific mRNA expressed corresponding to greater than or equal to approximately 0.001% of the poly (A) +mRNA.
- natural Bt genes were transcribed at levels wherein the amount of full-length specific mRNA produced was insufficient to be estimated using the Northern blot technique.
- transcription of a synthetic maize optimized Bt ICP gene designed to be highly expressed is increased to the extent that sufficiently high levels of the ICP accumulate to kill feeding insects.
- the design and synthesis strategy set forth herein represents the generally preferred methods for design and synthesis of a plant, specifically maize, optimized ICP gene. Those of ordinary skill the art will recognize that changes to this protocol are possible without undue experimentation to design and synthesize an ICP gene for expression in other plant species.
- the resulting maize optimized Bt ICP gene is identified m SEQ. ID. NO. 1.
- the maize specific optimized insecticidal gene sequence contains about 63% first choice codons, between about 22% to about 37% second choice codons and between about 15% to about 0. third and/or fourth choice codons, wherein the total percentage is 100%.
- the maize specific optimized insecticidal gene sequence contains about 63% first choice codons, between about 22% to about 37% second choice codons, and between 15% and 0% third choice codons, wherein the total percentage is 100%. Most preferably, the maize specific optimized insecticidal gene sequence contains about 63% first choice codons, at least about 22% second choice codons, about 7.5% third choice codons, and about 7.5% fourth choice codons, wherein the total percentage is 100%.
- B . th uringi ensi s CrylA(c) was used as the starting material.
- Analysis of the base composition of the native gene reveals significant disparity from maize genes.
- G+C guanosme plus cytosme
- maize genes fall into the G+C range of 45- 75% (Table 1) .
- coding regions of the genes were extracted from GenBank (Release 71) entries, and base compositions were calculated using the MacVectorTM program (IBI, New Haven, CT) . Intron sequences were ignored m the calculations. Group I and II storage protein gene sequences were distinguished by their marked difference m base composition.
- the very low G+C content of the native Bt ICP gene results in the generation of sequences mimicking or duplicating plant gene control sequences that are known to be highly A+T rich.
- the presence of some A+T-rich sequences within the DNA of the introduced gene e.g. TATA box regions normally found m gene promoters
- the presence of other regulatory sequences residing in the transcribed mRNA e.g. polyadenylation signal sequences (AAUAAA) , or sequences complementary to small nuclear RNAs involved in pre-mRNA splicing
- AAUAAA polyadenylation signal sequences
- one goal m the design of a maize optimized Bt ICP gene was to generate a DNA sequence having a higher G+C content, and preferably one close to that of maize genes coding for metabolic enzymes.
- Another goal m the design of the maize optimized Bt ICP gene was to generate a DNA sequence tnat not only has a higher G+C content, but by modifying sequence changes should be made so as to not hinder translation.
- any redundant codon present in the Baci ll us gene is a nonpreferred maize codon. These differences in codon bias are particularly evident in those cases where only two codon choices exist (i.e. Glu, Asp, Lys, Asn, Cys, Tyr, Phe, Gin, and His) .
- the ammo acid sequence of ICP was reverse translated into a DNA sequence, utilizing a nonredundant genetic code established from the codon bias table compiled for maize gene DNA sequences.
- the resulting DNA sequence which was completely homogeneous codon usage, was further modified m five reiterations to establish a DNA sequence that, besides having a higher degree of codon diversity, also contained strategically placed restriction enzyme recognition sites, desirable base composition, and a lack of sequences that might interfere with transcription of the gene, or translation of the product mRNA.
- Mze HD73 #1 trnc Synthesis of an ICP gene with preferred maize codons.
- a "Maize Genetic Code” was created, wherein each ammo acid is specified by a unique codon chosen on the basis of the most commonly occurring maize codons from Table 2 (frequencies as underlined numerals m the "Maize %" columns) .
- the native Bt ICP DNA sequence was translated into the corresponding protein sequence, and the ammo-termmal 610 ammo acids (which comprise the minimal insecticidal peptide of the ICP) were reverse-translated into a new DNA sequence based on the Maize Genetic Code.
- Mze HD73 #1 trnc was therefore comprised entirely of "preferred" maize codons and had a G+C content of 66%, somewhat higher than a "typical” maize gene (Table 1) .
- the new DNA sequence had 624 base changes from the native Bacill us ICP DNA sequence.
- Mze HD73 #2 trnc Elimination of enzyme recognition sites.
- the restriction enzymes Ba H I, Bgl II, Bel I, and Nco I are routinely used for the construction of gene expression cassettes. Therefore, it is preferable that a DNA sequence that encodes a protein of interest not contain recognition sites for these enzymes.
- Analysis of the DNA sequence of Mze HD73 #1 trnc revealed recognition sequences for three Bel I sites, three Bgl I sites, two Bgl II sites, one BamH I site, and one Nco I site. Alteration of the DNA sequence in such a fashion as to eliminate these sites forces the use of codons that are not the "preferred" maize codons, but rather are second or lower choice codons.
- nucleotide 249 of the sequence was changed from G to C, changing a leucine codon from CTG (the preferred maize codon, being present 31% of the time, Table 2; , to CTC (the second most frequently used leucine codon, occurring 28% of the time) .
- This single change eliminated a BcJ J recognition site and an overlapping Pvu II site. Twelve other changes and their rationales are given m Table 3.
- the resulting sequence was designated Mze HD73 #2 trnc, and encoded the identical protein as Mze HD73 #1 trnc.
- Mze HD73 #2 trnc contains an entire Open Reading Frame (ORF) m reading frames 1 and 3.
- ORF m frame 1 corresponds to that of the ICP, and verifies that no stop codons were inadvertently generated by the changes made to the sequence.
- the single ORF m frame 3 begins with the G of the ICP start codon, and continues uninterrupted to tne end of the sequence.
- Mze HD73 #3 trnc Modification of enzyme recognition sites to facilitate synthesis.
- GGTA is probably not sufficient to serve as a splice recognition site, since the 5' A residue of the consensus sequence is highly conserved splice recognition sites for both plant and animal RNAs, and the GGTA sequence occurs the E. coli ⁇ -glucuronidase coding region (which is expressed well in plant cells), and in exon 1 of maize alcohol dehydrogenase (Adh) 1.
- GGTA is found as part of all Kpn I recognition sites [GGTACC] which occur naturally m some plant genes, so it likely does not represent a potential splice donor
- the Mze HD73 #3 trnc DNA sequence was then searched for sequences similar to or identical with the poly A addition site signal consensus AATAAA. A perfect match was found m the native ICP gene sequence, but no homology was found to this engineered sequence, or shorter versions of it (down to AATA) in Mze HD73 #3 trnc. Sequences resembling an RNA polymerase II termination sequence -were searched using the template CA _ AGTNNAA, wnere N represents any of the four bases found in DNA. There were no matches at any level with N set 7 to 9.
- Mze HD73 #3 trnc Elimination of TA or GC doublets.
- Eukaryotic genes are relatively deficient m the nucleotide doublets TA and GC, and enriched in doublets TG and CT.
- Only two "preferred" maize codons (Table 2) contain TA or CG doublets: TAC (Tyr) and CGC (Arg) .
- the use of these codons in the synthetic sequence necessitates the generation of doublets we wished to avoid. Therefore, the benefit of using the preferred codon must be balanced against the detriment of creating an overabundance of "forbidden" doublets.
- substitution by the second choice codon does not eliminate the TA doublet, since it is also a component of that codon (TAT) .
- the second choice codon (AGG) is used m maize only slightly less frequently than tne first choice (26% vs 40% of the time), so the substitution of CGC by AGG was completed.
- the other codons that contain TA or CG doublets [GTA (Val) ; ATA (lie) ; TAG, TAA (End) ; TTA, CTA (Leu) ; GCG (Ala) ; CGG, CGA, CGT (Art) ; ACG (Thr) ; and CCG (ProM are either not acceptable for use in coding regions (e.g. the stop codons; , are found so infrequently in maize genes that they are not suitable for inclusion m a codon- biased sequence, or are members of codons sets that nave acceptable synonyms (Table 2) .
- CG and TA doublets are generated by juxtaposition of codons ending in C or T and codons beginning with G or A. Since none of the maize preferred codons end T, T/A juxtapositions are necessarily due to doublets internal to single codons, in gene versions using only preferred codons.
- CG doublets generated by ammo acid pairs are located by reviewing the protein sequence for juxtapositions of am o acids that are represented by maize preferred codons ending in C, with ammo acids represented by maize preferred codons starting with G.
- the "C-enders” are Gly (GGC) , Asp (GAC) , Ala (GCC) , Arg (CGC, Ser (AGC) , Asn (AAC) , lie (ATC) , Thr (ACC) , Cys (TGC) , Tyr (TAC) , Phe (TTC) , His (CAC, and Pro (CCC) ;
- the "G-starters” are Gly (GGC) , Glu (GAG) , Asp (GAC) , Val (GTG) , and Ala (GCC) (Table 5) .
- the frequency of codon occurrence in any organism's genes must be weighted relative to the number of synonymous codons that exist for the particular amino acid in the universal genetic code.
- the relative frequencies of maize usage of the Phe codon TTT (20%) clearly reflects a greater amount of counterselection (codon bias) than the identical relative frequency of the Pro codon CCT (20%), since there are only two Phe codons, and four Pro codons (Table 2) .
- Table 7 summarizes these and other changes made to the sequence of Mze HD73 #3 trnc to generate Mze HD73 #4 trnc.
- Mze HD73 #5 trnc+ Reduction of GC content and increase in codon diversity. Comparison of base doublet frequencies between versions #4 trnc+ and previous versions of the sequence (Table 3) revealed that the base composition had been altered towards reductions in CG base pairs, and towards abundances in TG and CT base pairs. However, version #4 trnc+ still had a relatively high G+C content (62%) compared to the target of 55-60% for maize genes. Reduction of this parameter necessitated using more alternate codons containing A and/or T. Table 8 summarizes the changes made to the sequence of Mze HD73 #4 trnc+ to generate Mze HD73 #5 trnc+ .
- um ers in paren eses are requenc es o usage n ma ze genes rom a e
- the Ser codons AGC and TCC are considered to be interchangeable. Analogous frequency similarities exist for the Val codons GTG and GTC, Leu codons CTG and CTC, and Ala minor codons GCT and GCG. m) Leu and Ser minor codons TTG and TCT are acceptable when they follow a C-endmg codon, so that additional CT doublets are generated. TTG offers the added feature of increasing the TG doublet count. IV) Arg codon AGG may be substituted for the preferred codon CGC (see discussion previous section) . Although AGG occurs in maize genes at substantially lower frequency than the preferred codon, it is found twice as often as the third choice codon.
- v) Minor codons such as GAT (Asp) , GAA (Glu) , ATT (lie), ACT (Thr) , and GTT (Val), which have obviously been counterselected in maize, should be used sparingly, if possible. It is preferable that they be placed before or after codons that will contribute to the formation of a CT or TG doublet. Because they are a feature of native maize genes, their inclusion in a synthetic gene need not be avoided entirely.
- Mze HD73 #6 trnc+ Only a few changes were made to the sequence of Mze HD73 #5 trnc+ to generate the final version of the gene, Mze HD73 #6 trnc+ . (summarized in Table 10) .
- Table 12 lists the codon usage patterns of the native Bacill us HD73 gene, the Mze HD73 #1 trnc+ gene, and Mze HD73 #6 trnc+ .
- Comparison with the DNA sequence published by Perlak et al. (PNAS, 88 (1991) 3324) reveals that the present maize optimized Bt ICP gene differs at 422 positions out of 1845 (23% difference) , and the encoded proteins differ at amino acids 206, 227, 245, 254, 289, and 313 (6 changes out of 615 amino acids, not including the terminal prolines) .
- Table 14 set forth below further illustrates the teachings of the method of modifying a gene by using preferred and non-preferred maize codons to make a plant optimized nucleotide sequence.
- 6 of the 8 fourth choice codons are used a total of 47 times out of 618 possible times, or 7.5% of the time.
- MZE HD73 #6 trnc+ is 63% homologous to a pure plant optimized nucleotide sequence.
- a nucleotide sequence corresponding to Mze HD73 #6 trnc+ was synthesized m a series of Polymerase Cham Reactions (PCR) as taught m U.S. Patent No. 4,683,202 to Mullis and U.S. Patent No. 4,683,195 to Mullis et al., by stepwise addition of overlapping oligonucleotides.
- the procedure relies on PCR amplification of intermediate synthesis product, followed by amplification of extensively modified large DNA fragments prior to cloning. Following one round of amplification, the intermediate product is purified, annealed to the next set of overlapping primers, and amplified. Entire genes can thus be synthesized without annealing, ligation, transformation and selection of intermediate reaction products; steps that are necessary with other approaches.
- Taq polymerase the enzyme used m PCR amplification, lacks 3' -5' exonuclease activity, and therefore is unable to 'proofread' the nascent sequence and remove mismcorporated nucleotides. Under certain conditions (55 C C annealing temperature and 200 ⁇ M deoxynucleotide concentration) , the polymerase was calculated to mismcorporate nucleotides at a frequency of 5 x 10 "6 (GeIfland et al., PCR Protocols, (1989) , Academic Press, Inc., San Diego, CA) .
- Each part upon completion of the synthesis, was designed to contain at each of its ends a unique restriction site. These sites were used to join the individual parts together to construct the contiguous sequence encoding 617 ammo acids.
- the 5' part was designed to have unique 5' Nco I and 3' Xho I sites at the ends, the central part was desiqned to have unique 5' Xho I and 3' Kpn I sites at the ends, and the 3' part was designed to have unique 5' Kpn I and 3' BamH I sites (see Figure 1A) .
- the 5 '-most ICP gene fragment of 653 basepairs was synthesized from 12 overlapping 61 to 86 base long oligonucleotides m 6 PCR steps. All oligonucleotides were designed to produce 18 to 20 base overlaps during the successive PCR steps. In each case, synthesis of the fragment was carried out from the "mside-out", as is exemplified in Figure IB. Step 1 of the syntnesis process was begun by annealing of oligonucleotides Btl and Bt2. Only in the central area of overlap between the two is the annealed molecule double stranded. The remainder of the molecule was made double stranded by extension with the Taq
- this double stranded molecule was denatured, then annealed to and reamplified with oligonucleotides Bt2 and Bt4.
- this double stranded molecule (corresponding to the sequence of Bt3, Btl, Bt2 and Bt4) was denatured, annealed to and amplified with oligonucleotides Bt5 and Bt6. This process was repeated until the sequence was extended to a 653 bp double stranded molecule corresponding to the entire sequence of the 5' part of the Bt gene (see Figure IB).
- the 584 bp central fragment was synthesized using 10 overlapping 75 to 83 base long oligonucleotides in 5 PCR steps and the 3'-most ICP gene fragment of 657 bp was synthesized using 12 overlapping 59 to 84 base oligonucleotides m 6 PCR steps.
- each of the gene parts cloned m pBlueScript ("pBS", Stratagene, La Jolla, CA) vectors were verified by sequence analysis. Corrections, when necessary, were made using a PCR mutagenesis approach. The corrections were resequenced prior to -joining of the individual fragments into the complete gene.
- the Bt ICP gene was constructed from a total of 34 oligonucleotides ranging m size from 59 to 86 nt. The sequence of all 34 oligonucleotides is presented m Table 15.
- oligonucleotide For each oligonucleotide, the name, gene fragment sequence, location in the complete ICP gene, and length (in bases) are shown. Nucleotide locations marked with re indicate that the sequence of the oligonucleotide corresponds to the reverse complement of the nucleotide sequence of the top (coding) strand of the gene.
- oligonucleotide overlaps were a minimum of 18 nt; ii) The 3'-most base of each oligonucleotide was chosen to be G or C; iii) The 5'- most base of each oligonucleotide was chosen adjacent to and downstream of a T residue in the sequence, in order to avoid problems with non-template addition of A residues at the 3' end of the opposite strand (Clark et al., Nucl.
- the maize optimized nucleotide sequence coding for Bt ICP is expressed in plants at an enhanced level when compared to that observed with natural Bt structural genes. Expression of the maize optimized Bt ICP nucleotide sequence requires transformation of a plant cell with an appropriate vector.
- the maize optimized nucleotide sequence for Bt ICP was combined with a promoter functional in plants, where the structural gene and the promoter region being in such position and orientation with respect to each other that the structural gene can be expressed in a cell m which the promoter region is active, thereby forming a functional gene.
- the promoter regions include, but are not limited to, bacterial and plant promoter regions.
- the promoter is selected from the group consisting of mducible promoters, constitutive promoters, temporal or developmentally-regulated promoters, tissue-preferred, and tissue-specific promoters .
- the vector includes an MSV (Maize Streak Virus) leader sequence, a 35S promoter, and an enhancer specific for maize, such as an Adh mtron 1 or Adh mtron 6 as further described in the Examples.
- MSV Maize Streak Virus
- Adh mtron 1 or Adh mtron 6 an enhancer specific for maize, such as an Adh mtron 1 or Adh mtron 6 as further described in the Examples.
- the DNA segment carrying the combination is contained by a cell.
- Combinations which include plant promoter regions are contained by plant cells, which, m turn, may be contained by plants or seeds.
- Combinations which include bacterial promoter regions are contained by bacteria, e.g., Bt or E. coli .
- bacteria e.g., Bt or E. coli .
- the recombinant DNA molecule carrying a maize optimized Bt ICP gene under promoter control can be introduced into plant tissue by any means known to those skilled in the art.
- the technique used for a given plant species or specific type of plant tissue depends on the known successful techniques.
- novel means are developed for the stable insertion of foreign genes into plant cells and for manipulating the modified cells, skilled artisans will be able to select from known means to achieve a desired result.
- the doubly enhanced promoters can be used to express foreign genes m maize as well as dicots or other monocots. More specifically, dicots include but are not limited to soybeans, legumes, rapeseed, cotton, sunflower, tomatoes, potatoes, sugar beets, alfalfa, cloves and peanuts. Monocots include but are not limited to maize, wheat, sorghum, oats, rye, barley, rice, millets, sugar cane and grasses.
- promoters which may be modified with the MSV leader sequence adhl, adh6, or other mtrons (SEQ. ID. NOS . 43, 44, 45, 46 and 47) include but are not limited to octopine synthase promoter, nopaline synthase promoter and manopine synthetase promoter.
- Plant promoters can also be further modified by the teachings herein and include but are not limited to ribulose-1, 6-biphosphate (RUBP) carboxylase small subunit (ssu), beta-conglycinin promoter, phaseolin promoter, ADH promoter, actin, ubiquitin, zein, oleosin, napin, ACP, heat-shock promoters, and tissue specific promoters or pollen-specific, embryo specific, corn silk specific, cotton fiber specific, root specific, seed endosperm specific promoters and the like.
- RUBP ribulose-1, 6-biphosphate
- Electroporation technology has also been used to transform plants, see WO 87/06614 to Boyce Thompson Institute, 5,472,869 and 5,384,253 both to Dekalb, WO9209696 and W09321335 both to PGS . All of these transformation patents and publications are incorporated by reference.
- tissue which is contacted with the foreign genes may vary as well. Such tissue would include but would not be limited to embryogenic tissue, callus tissue type I and II, hypocotyl, meristem, and the like. Almost all plant tissues may be transformed during dedifferentiation using appropriate techniques within the skill of an artisan.
- selectable marker Another variable is the choice of a selectable marker.
- the preference for a particular marker is at the discretion of the artisan, but any of the following selectable markers may be used along with any other gene not listed herein which could function as a selectable marker.
- selectable markers include but are not limited to ammoglycoside phosphotransferase gene of transposon Tn5 (Aph II) which encodes resistance to the antibiotics kanamycm, neomycm and G418, as well as those genes which code for resistance or tolerance to glyphosate; hygromycin; methotrexate; phosphinothncm (bar) ; lmidazol ones, sulfonylureas and triazolopyrimidme herbicides, such as chlorosulfuron; bromoxynil, dalapon and the like.
- reporter gene In addition to a selectable marker, it may be desirous to use a reporter gene. In some instances a reporter gene may be used without a selectable marker. Reporter genes are genes which are typically not present or expressed m the recipient organism or tissue. The reporter gene typically encodes for a protein which provide for some phenotypic change or enzymatic property. Examples of such genes are provided m K. Weismg et al . Ann. Rev. Genetics, 22, 421 (1988), which is incorporated herein by reference. A preferred reporter gene is the glucuromdase (GUS) gene. Once introduced into the plant tissue, the expression of the structural gene may be assayed by any means known to the art, and expression may be measured as mRNA transcribed or as protein synthesized.
- GUS glucuromdase
- plant tissues and whole plants can be regenerated therefrom using methods and techniques well-known in the art.
- the regenerated plants are then reproduced by conventional means and the introduced genes can be transferred to other strains and cultivars by conventional plant breeding techniques.
- Oligonucleotides were synthesized on either the Applied Biosystems Inc., DNA synthesizer model 380A or model 390 using 0.2 ⁇ M columns and FOD phosphoramidites and standard cyanoethyl chemistry; synthesis was done in the Trityl-Off mode. Following synthesis on the Model 380A synthesizer, each oligonucleotide was cleaved off the column and deprotected at 50°C for 1 hr. and dried down by evaporation at 50°C. The oligonucleotides were resuspended in 300 ⁇ l TE buffer (10 mM Tris HCl pH 8.0, 1 mM EDTA) and the concentration was determined by measuring the absorbance at 260 nm.
- Oligonucleotides were purified by electrophoresis on 12% denaturing polyacrylamide gels (PAGE) .
- a PAGE gel stock solution of 300 mis was made by dissolving 126 g urea in 30 ml lOx Tris Borate EDTA buffer (TBE; lx TBE is 0.9 M Tris-borate, 2 mM EDTA) and 90 ml 401 acrylamide stock and adjusting the volume of the solution to 300 mis with H 2 0.
- the gel solution was filtered through a 0.2 ⁇ m filter.
- 40 mis of the PAGE stock was used to pour a 5-well gel using a Hoeffer Sturdier gel apparatus. Polymerization was initiated by addition of 350 ⁇ l 10% ammonium persulfate and 35 ⁇ l TEMED prior to pouring.
- Each oligonucleotide was prepared as follows:
- 300 to 500 ⁇ g of oligonucleotide was diluted to 60 ⁇ l with TE buffer, then 60 ul of formamide gel loadinq duffer (10 ml formamide, 10 mg xylene cyano_ FF, 1 J mq bromophenol blue, 200 ⁇ l 0.5 M EDTA pH 8.0 i was ad ⁇ ed and the sample was boiled for 5 minutes and chilled on ice. The samples were loaded on the gel using a sequencing pipet tip. Electrophoresis was carried out m lx TBE at 300 volts for 3 hrs.
- the acrylamide gel was transferred to SaranWrap 11 , placed on a white background (e.g., X-Ray intensifying screen) , and exposed to short wave UV light.
- a white background e.g., X-Ray intensifying screen
- the DNA bands of appropriate size were excised from the gel and the DNA was eluted by diffusion.
- Each gel slice was macerated with a glass rod and incubated in 1.5 ml of oligo elution buffer (100 mM Tris HCl pH 8.0, 500 mM NaCl, 5 mM EDTA) with constant agitation a rolling drum at 37°C for 16 hours.
- the polyacrylamide slurry was filtered through a 3 cc syringe containing a glasswool plug and an attached 0.2 ⁇ m filter.
- the eluted oligonucleotide was concentrated by centrifugation for 2 hrs.
- oligonucleotide was recovered m a final volume of 30 to 40 ⁇ l. Concentration was determined by measurement of the absorbance at 260 nm.
- oligonucleotide synthesis As an example of the result of oligonucleotide synthesis, the gel purification of oligonucleotides Bt6 - BtlO is shown in Figure 2.
- Figure 2 also shows two successful syntheses with the 380A synthesizer (Bt9 and BtlO) and two successful syntheses with the 390 synthesizer (Bt6 and Bt7) .
- EXAMPLE 2 PCR Amplification.
- PCR amplifications were done m 100 ⁇ _ reactions containing 20 mM Tris HCl pH 8.3, 1.5 mM MqCl , 25 mM KC1, 200 ⁇ M each of dATP, dGTP, dCTP and dTTP, and 5 units of Taq Polymerase (Perkm Elmer Cetus) . Template and PCR primer concentrations varied depending on the step m the protocol.
- template was generated for each fragment by amplification with 0.5 ⁇ M of each of the primers of the first set (see Figure 1) the following regime: 1 minute denaturation at 94°C, 2 minutes annealing at 55°C and 3 minutes extension at 72°C for 30 cycles, followed by an additional extension period of 7 minutes at 72°C.
- the reaction products were loaded on a 5% native polyacrylamide gel and electrophoresed at 40 volts for 2.5 hours m lx TBE. BRL 123 bp ladder run m a parallel lane was used as size standard. Following electrophoresis the gel was stained for 1 hr. m water containing 0.5 ⁇ g/ml ethidium bromide.
- the fragments of expected size were cut out of the gel and purified from the gel slice as described for the oligonucleotide purification (see above) , with the exception that following filtering through glasswool and 0.2 ⁇ m filter, the DNA was concentrated by precipitation with 2.5 volumes of ethanol, 20 ⁇ g glycogen, and 0.05 volume of 8 M LiCl. The DNA was resuspended m 40 ⁇ l TE buffer.
- the second PCR step m the synthesis of each fragment was carried out the same reaction mixture as the first step except that 5 ⁇ l of gel purified pro ⁇ uct of step 1 was used as template and the oligonucleotide concentration was 0.2 ⁇ M.
- the dimer-sized bands in each lane are considered to be artifacts of the electrophoresis, because gel purified DNA from monomer-size bands when re-run on a gel also gave this dimer-size band.
- the final product for each of the gene fragments was digested with the enzymes recognizing the restriction sites built in the end of each fragment (see Figure 1A) and ligated to pBS DNA cut with the same enzymes. The ligation products were transformed into competent E . coli DH5 ⁇ cells, and isolates carrying pBS plasmids containing the appropriate fragments were identified. DNA sequence of the ICP gene portion of these plasmids was determined, and five nucleotide differences from the Mze HD73 #6 trnc+ sequence were found.
- Errors in the ICP gene fragments were corrected by PCR mutagenesis. For each correction two PCR reactions were set up. One PCR reaction amplified the 5' half of the fragment, using a 5' end oligonucleotide and the error-correcting oligonucleotide. The other PCR reaction amplified the 3' half of the fragment using the complementary error correction oligonucleotide and a 3' end oligonucleotide. The 5' and 3' corrected fragments were gel purified and -joined together a second step PCR reaction by amplification with only the 5' end and 3' end oligonucleotides as primers.
- Oligonucleotides used in the error correction were synthesized and gel purified as described above. PCR reaction conditions were as described above, except that annealing was done at 50°C and 25 cycles were used. Fragments were gel purified using the GeneClean kit available from BiOlOl.
- EXAMPLE 4 E. coli Expression.
- the ICP was inserted as a 1862 base pair Nco I BamH I DNA fragment the Nco I and BamH I sites of cytoplasmic expression vector pET-9d (Novagen, Madison, WI . ) .
- One microgram of plasmid was transformed into 0.2 mis of competent cells of E. col i strain BL21 (which was available for purchase from Novagen, Madison, WI . ) and plated on LB plates containing kana ycm at 25 ⁇ g/ml (for plasmid pET-9d) .
- soluble and aggregated protein fractions were prepared as follows. Cell pellet was frozen and thawed twice, to aid in cell lysis, and the lysate was resuspended m 1 ml of lysis buffer (lO M Tris HCl pH 8.0, ImM EDTA, 150 mM NaCl, 0.1% Triton X100, 100 g/ml DNasel, 100 ug/ml RNaseH, 1 mg/ml lysozyme) and incubated at 37°C until it was no longer viscous. Soluble protein was separated from aggregated denatured proteins by centrifugation at 4 C C for ten minutes. The insoluble pellet was resuspended m approximately 300 ul of the above lysis buffer. Both fractions had a final volume of 0.5 ml.
- the size of the anti-ICP cross-reactive protein produced in E. coli corresponds closely to the size of 68 kD predicted by the sequence of the ICP gene.
- the native ICP is slightly smaller (Mw 66 kD) compared to the product of the modified ICP gene (lanes 5, 6 and 7 .
- the toxm is produced as a 130 kL protoxm. Upon mgestion by Lepidopteran insects, the protoxm is solubilized and activated by proteolytic cleavage. This proteolysis produces an active toxm moiety of 60-70 kD, depending on the strain of B. thuringi ensi s .
- proteolytic processing occurs in the center of the protoxm, and separates the toxm moiety from the C-terminal domain. Processing also occurs at the extreme N-termmus between ammo aci ⁇ s Arq 28 and lie 29, and is probably carried out by a serine- type protease.
- Ammo terminal protein sequencing cf trypsm activated protoxm of CrylA(b) and CrylC identified isoleucine at position 29 as the N-termmus (Hofte et al., Microbiological Rev., 53 (1989) 242) .
- the E. coli extract would remove the N-termmal 28 ammo acids.
- the extractea protein was not quantified because the protein itself s insoluble ana aggregates with cellular debris.
- Protein concentrations were determined using the BioRad protein assay. Proteins were analyzed on 12.5% sodium dodecyl sulfate-polyacrylamide gels (SDS- PAGE) made m a Hoeffer Mighty Small mmigel device, or on a Danchi mmigel device according to the manufacturers' recommendations. Staining for protein was done as described (Sambrook et al., Molecular Cloning: A Laboratory Manual, (1989), 2nd Ed., Cold Spring Harbor Press, Cold Spring Harbor, NY) , ICP was specifically detected by protein gel blot analysis (Western blotting) with rabbit antiserum raised against purified B .
- the membrane was incubated with primary antiserum at a 1:500 dilution m blocking reagent, followed by washing three times in 100 ml TBS- Tween (no milk) at room temperature for 10 minutes. The membrane was incubated for 1 hr.
- m blocking reagent containing secondary antiserum (goat anti-rabbit-IgG conjugated to horseradish peroxidase; Bio-Rad Laboratories, Hercules, CA) , then washed three times in 100 ml TBS-Tween at room temperature for 10 minutes.
- the filter was incubated m 10 mis of reagent A+B (1:1; ECL kit) for 1 minute, excess liquid was drained off, and the membrane was exposed to Hyperfllm-ECL film for 10 sec. to 1 minute. ECL film was processed using standard developer and fixer. ICP signals were scanned with a Model 620 video densitometer (Bio-Rad) and the concentration was determined by comparison with scans of ICP standards electrophoresed on the same gel using 1-D Analyst software (Bio-Rad) .
- Figure 4 illustrates expression of ICP in E. coli and the concentration of such expressions.
- ICP expressed in E . coli and extracted as indicated in Example 4 was used for feeding assays m Manduca sexta (tobacco hornworm) . Neonate larvae were allowed to feed on artificial diets into which ICP or control samples were incorporated. After 4 days, their weights and mortality were determined.
- This section describes molecular manipulations which result a duplication of the expression-enhancer element of a plant promoter. This duplication has been shown (Kay et al . , Science 236 (1987) 1299) to result m increased expression m tobacco plants of marker genes whose expression is controlled by such a modified promoter.
- the sequences referred to in this discussion are derived from the Cabb S strain of Cauliflower Mosaic Virus (CaMV) . They are available as the MCASTRAS sequence of GenBank, and published by Franck et al. (Cell 21 (1980) 285) . All of the DNA sequences are given m the conventional 5' to 3' direction.
- the starting material is plasmid pUCl3/35S (-343) as descirbed by Odell et al . (Nature 313 (1985) 810) .
- This plasmid comprises, starting at the 3' end of the Sma I site of pUCl3 (Messing, Methods m Enzy ology 101 (1983) 20) , and reading on the strand contiguous to the noncod g strand of the lacZ gene of pUC13, nucleotides 6495 to 6972 of CaMV, followed by the linker sequence CATCGATG (which encodes a Cla I recognition site.
- DNA polymerase The blunt-ended DNA was the ligated to synthetic oligonucleotide linkers having the sequence CCCATGGG, which includes an Nco I recognition site.
- the ligation reaction was transformed into competent Escheri chia coli cells, and a transformant was identified that contained a plasmid (named p00#l) that had an Nco I site positioned at the former Cla I site.
- DNA of pOO.fl was digested with Nco I and the compatible ends of the large fragment were religated, resulting m the deletion of 70 bp from pOO#l, to generate intermediate plasmid pOO#l NCO ⁇ .
- pOO#l NCO ⁇ DNA was digested with EcoR V, and tne blunt ends were ligated to Cla I linkers having the sequence CATCGATG.
- An E. coli transformant harboring a plasmid having a new Cla I site at the position of tne previous EcoR V site was identified, and the plasmi ⁇ was name ⁇ pOO#l NCO ⁇ RV>Cla.
- DNA of pOO#l NCO ⁇ RV>Cla DNA was digested with Cla I and Nco I, and the small (268 bp) fragment was purifed from an agarose gel.
- This fragment was then ligated to the 3429 bp Cla I/Nco I fragment of pUCl3/35S (-343) prepared above in step 1, and an E. coli transformant that harbored a plasmid having Cla I/Nco I fragments 3429 and 268 bp was identified.
- This plasmid was named pUC13/35S En.
- pUC13/35S En DNA was digested with Nco I, and the protruding ends were made blunt by treatment with T4 DNA polymerase. The treated DNA was then cut with S a I, and was ligated to Bgl II linkers having the sequence CAGATCTG.
- An E. col i transformant that harbored a plasmid in which the 416 bp Sma I/Nco I fragment had been replaced with at least two copies of the Bgl II linkers was identified, and named p35S En 2 .
- NOTE The tandomization of these Bgl II linkers generate, besides Bgl II recognition sites, also Pst I recognition sites, CTGCAG] .
- the DNA structure of p35s En 2 is as follows: Beginning with the nucleotide that follows the third C residue of the Sma I site on the strand contiguous to the noncod g strand of the lacZ gene of pUC13; the linker sequence CAGATCTGCAGATCTGCATGGGCGATG (SEQ. ID. NO. 48) , followed by CaMV nucleotides 7090 to 7344, followe ⁇ by the Cla I linker sequence CATCGATG, followed by CaMV nucleotides 7089 to 7443, followed by the Hind III linker sequence CAAGCTT, followed by the rest of pUC13 sequence.
- This structure has the feature that the enhancer sequences of the CaMV 35S promoter, which lie m tne region upstream of the EcoR V site in the viral genome (nts 7090 to 7344) , have been duplicated.
- This promoter construct incorporates the native 35S transcriptior start site, which lies 11 nucleotides upstream of the first A residue of the Hind III site.
- Example 7B Plasmids utilizing the 35S promoter and the Agrobacte ⁇ um NOS Poly A sequences:
- the starting material for the first construct is plasmid pBl221, purchased from CLONTECH (Palo Alto, CA) .
- This plasmid contains a slightly modified copy of the CaMV 35S promoter, as described in Bevan et al . (1985), Baulcombe et al., (1986), Jefferson et al., (1986, 1987) and Jefferson (1987) . Beginning at the 3' end of the Pst I site of pUC19 (Yamsch-Perron et al .
- the sequence is comprised of the linker nucleotides GTCCCC, followed by CaMV nucleotides 6605 to 7439 (as described m Example 7A) , followed by the linker sequence GGGGACTCTAGAGGATCCCCGGGTGGTC AGTCCCTT (SEQ. ID. NO. 49), wherein the underlined bases represent the BamH I recognition sequence. These bases are then followed by 1809 bp comprising the coding sequence of the E.
- coli uidA gene which encodes the ⁇ -glucuromdase (GUS) protein, and 55 bp of 3' flanking bases that are derived from the E. coli genome (Jefferson, 1986), followed by the Sac I linker sequence GAGCTC, which is then followed by the linker sequence GAATTTCCCC (SEQ. ID. NO. 50 .
- These bases are followed by the RNA transcription termmation/polyadenylation signal sequences derived from the Agrojbacteriujn tumefaci ens nopalme synthase (NOS) gene, and comprise the 256 bp Sau3A I fragment corresponding to nucleotides 1298 to 1554 of DePicker et al. (1982) , followed by two C residues, the Eco RI recognition sequence GAATTC, and the rest of pUC19.
- NOS nopalme synthase
- pBl221 DNA was digested with EcoR I and BamH I, and the 3507 bp fragment was purified from an agarose gel.
- pRAJ275 CLONTECH, Jefferson, 1987
- DNA was digested with EcoR I and Sal I, and tie 1862 bp fragment was punfie ⁇ from an agarose gel. These two fragments were mixed together, and complementary synthetic oligonucleotides having the sequence GATCCGGATCCG (SEQ. ID. NO. 51) and TCGACGGATCCG (SEQ. ID. NO. 52) were added.
- pKA882 DNA was digested with Sac I, the protruding ends were made blunt by treatment with T4 DNA polymerase, and the fragment was ligated to synthetic BamH I linkers having the sequence CGGATCCG.
- An E. coli transformant that harbored a plasmid having BamH I fragments of 3784 and 1885 bp was identified and named pKA882B.
- pKA882B DNA was digested with BamH I, and the mixture of fragments was ligated.
- An E. col i transformant that harbored a plasmid that generated a single 3783 bp fragment upon digestion with BamH I was identified and named p35S/NOS.
- This plasmic has the essential DNA structure of pBl221, except that the coding sequences of the GUS gene have been deleted. Therefore, CaMV nucleotides 6605 to 7439 are followed by the linker sequence GGGGACTCTAGAGGATCCCGAATTTCCCC (SEQ. ID. NO. S3) , where the single underlined bases represent an Xba I site, and the double underlined bases represent a BamH I site.
- p35S/NOS DNA was digested with EcoR V and Pst I, and the 3037 bp fragment was purified and ligated to the 534 op fragment obtained from digestion of p35S En- DNA with EcoR V and Pst I.
- An E. coli transformant was identified that harbored a plasmid that generated fragments of 3031 and 534 bp upon digestion with EcoR V and Pst I, and the plasmid was named p35S En 2 /NOS.
- This plasmid contains the duplicated 35S promoter enhancer region described for p35S En 2 m Example 7A Step 5, the promoter sequences being separated from the NOS polyadenylation sequences by linker sequences that include unique Xba I and BamH I sites.
- Example 7C Construction of a synthetic untranslated leader
- This example describes the molecular manipulations used to construct a DNA fragment that includes sequences which comprise the 5' untranslated leader portion of the major ⁇ ghtward transcript of the Maize Streak Virus (MSV) genome.
- the MSV genomic sequence was published by Mullmeaux et al. , (1984), and Howell (1984), and the transcript was described by Fenoll et al. (1988) .
- the entire sequence, comprising 154 bp, was constructed in three stages (A, B, and C) by assembling blocks of synthetic oligonucleotides.
- a Block Complementary oligonucleotides having the sequence
- GATCCAGCTGAAGGCTCGACAAGGCAGATCCACGGAGGAGCTGATATTTGGTGGACA SEQ. ID. NO. 54
- AGCTTGTCCACCAAATATCAGCTCCTCCGTGGATCTGCCTTGTCCAGCCTTCAGCTG SEQ. ID. NO. 55
- blunty ends 4-base single stranded protruding ends [hereinafter referred to as "sticky ends"] that are compatible with tnose generated by BamH I on one end of the molecule (GATC) , and with Hind Ill- generated single stranded ends on the other end of the molecule (AGCT) .
- Such annealed molecules were ligated into plasmid pBluescript SK(-) [hereinafter called pBSK; Stratagene Cloning Systems, LaJolla, CA] , that had been digested with BamH I and H d III.
- the sequence of these oligonucleotides is such that, when ligated onto the respective BamH I and Hmd III sticky ends, the sequences of the respective recognition sites are maintained.
- An E . coli transformant harboring a plasmid containing the oligonucleotide sequence was identified by restriction enzyme analysis, and the plasmid was named pMSV A.
- DNA of pMSV A was digested with Hmd III and Sal I, and was ligated to the above annealed oligonucleotides.
- An E. coli transformant harboring a plasmic containing the new oligonucleotides was identified by restriction enzyme site mapping, and was named pMSV AB.
- TCGAGGGATCCAAGCTTGATATCCCATGGCTGAATGCTTATCCCGTGCCTGGAACAA ATGGC (SEQ. ID. NO. 59) were synthesized and purified oy standard procedures.
- the oligonucleotides incorporate bases that comprise recognition sites (underlined ) for Nco I (CCATGG) , EcoR V (GATATC) , Hmd III (AAGCTT) , and BamH I (GGATCC) .
- Annealing of these nucleotides into double-stranded structures leaves 4-base sticky ends that are compatible with those generated by Xma I on one end of the molecule (CCGG) , and with Xho I-generated sticky ends on the other end of the molecule (TCGA) .
- Such annealed molecules were ligated into pMSV AB DNA that had been digested with Xma I and Xho I.
- An E . coli transformant harboring a plasmid containing the oligonucleotide sequence was identified by restriction enzyme analysis, and DNA structure was verified by sequence analysis.
- the plasmid was named pMSV CPL; it contains the A, B and C blocks of nucleotides m sequential order ABC.
- L 5' untranslated leader sequence
- CP MSV coat protein
- pMSV CPL DNA was digested at the Sma I site corresponding to base 277 of the MSV genomic sequence, and the DNA was ligated to Bgl II linkers having the sequence CAGATCTG.
- An E . coli transformant harboring a plasmic having a unique Bgl II site at the position of the former Sma I site was identified and verified by DNA sequence analysis, and the plasmid was named pCPL-Bgl.
- Example 7D Construction of a deleted version of the maize alcohol dehydrogenase 1 (Adhl) mtron 1
- the starting material is plasmid pVW119, which was obtained from V. Walbot, Stanford University, Stanford, CA.
- This plasmid contains the DNA sequence of the maize Adhl.S gene, including mtron 1, from nucleotides 119 to 672 [numbering of Dennis et al . (1984) ], and was described in Callis et al . (1987) .
- the sequence following base 672 of Dennis et al. (1984) is GACGGATCC, where the underlined bases represent a BamH I recognition site.
- the entire mtron 1 sequence, with 14 bases of exon 1, and 9 bases of exon 2 can be obtained from this plasmid on a 556 bp fragment following digestion with Bel I and BamH I.
- Plasmid pSG3525a(Pst) DNA was digested with BamH I and Bel I, and the 3430 bp fragment was purified from an agarose gel.
- NOTE The structure of plasmid pSG3525a(Pst) is not directly relevant to the end result of this construction series. It was constructed during an unrelated series, and was chosen because it contained restriction recognition sites for both Bel I and BamH I, and lacks Hmd III and Stu I sites.
- DNA of plasmid pVWlL9 was digested with BamH I and Bel I, and the gel purified fragment of 546 bp was ligated to the 3430 bp fragment.
- An E. coli transformant was identified that harbored a plasmid that generated fragments of 3430 and 546 upon digestion with BamH I and Eel I. This plasmid was named pSG AdhAl .
- DNA of pSG AdhAl was digested with H d III, [which cuts between bases 209 and 210 of the Dennis et al . , (1984) sequence, bottom strand], and with Stu I, which cuts between bases 554 and 555. The ends were made flush by T4 DNA polymerase treatment, and then ligated. An E.coli transformant that harbored a plasmid lacking Hmd III and Stu I sites was identified, and the DNA structure was verified by sequence analysis. The plasmid was named pSG AdhAl ⁇ . In this construct, 344 bp of DNA have been deleted from the interior of the mtron 1. The loss of these bases does not affect splicing of this mtron. The functional mtron sequences are obtained on a 213 bp fragment following digestion with Bel I and BamH I.
- DNA of plasmid pCPL-Bgl (Example 7C Step 4), was digested with Bgl II, and the linearized DNA was ligated to the 213 bp Bel I/BamH I fragment containing the deleted version of the Adhl.S mtron sequences from pSG AdhAl ⁇ .
- Bgl II, Bel I, and BamH I The sticky ends generated by digestion of DNA with Bgl II, Bel I, and BamH I are compatible, but ligation of the BamH I or Bel I sticky ends onto ones generated by Bgl II creates a sequence not cleaved by any of these three enzymes.
- coli transformant was identified by restriction enzyme site mapping that harbored a plasmid that contained the mtron sequences ligated into the Bgl II site, m the orientation such that the Bgl II/Bcl I juncture was nearest the 5' end of the MSV CPL leader sequence, and the Bgl 11/ BamH I juncture was nearest the 3' end of the CPL. This orientation was confirmed by DNA sequence analysis.
- the plasmid was named pCPL AIII ⁇ .
- the MSV leader/mtron sequences can be obtained from this plasmid by digestion with BamH I and Nco I, and purification of the 373 bp fragment.
- Example 7E Construction of plant expression vectors based on the enhanced 35S promoter, the MSV CPL, and the deleted version of the Adhl intron 1
- DNA of plasmid p35S En 2 /NOS was digested with BamH I, and the 3562 bp linear fragment was ligated to a 171 bp fragment prepared from pMSV CPL DNA digested with BamH I.
- This fragment contains the entire MSV CPL sequence described Example 7C.
- An E. coli transformant was identified by restriction enzyme site mapping that harbored a plasmid that contained these sequences in an orientation such that the Nco I site was positioned near the NOS Poly A sequences.
- This plasmid was named p35S En 2 CPL/NOS. It contains the enhanced version of the 35S promoter directly contiguous to the MSV leader sequences, such that the derived transcript will include the MSV sequences in its 5' untranslated portion.
- DNA of plasmid pKA882 was digested with Hind III and Nco I, and the large 4778 bp fragment was ligated to an 802 bp Hind III/Nco I fragment containing the enhanced 35S promoter sequences and MSV leader sequences from p35S En 2 CPL/NOS.
- An E. coli transformant harboring a plasmid that contained fragments of 4778 and 802 bp following digestion with Hind III and Nco I was identified, and named pDAB310.
- the enhanced version of the 35S promoter is used to control expression of the GUS gene.
- the 5' untranslated leader portion of the transcript contains the leader sequence of the MSV coat protein gene.
- DNA of plasmid pDAB310 was digested with Nco I and Sac I.
- the large 3717 bp fragment was purified from an agarose gel and ligated to complementary synthetic oligonucleotides having the sequences CGGTACCTCGAGTTAAC
- DNA of plasmid pDAB1148 was digested with Bam HI and Nco I, the large 3577 bp fragment was purified from an agarose gel and ligated to a 373 bp fragment purified from pCPL AIII ⁇ (Example 7D Step 3) following digestion with Bam HI and Nco I.
- An E. coli transformant was identified that harbored a plasmid with BamH I and Nco I, and the plasmid was named pDAB303.
- This plasmid has the following DNA structure: beginning with the base after the final G residue of the Pst I site of pUC19 (base 435) , and reading on the strand contiguous to the coding strand of the lacZ gene, the linker sequence ATCTGCATGGGTG (SEQ. ID. NO. 63), nucleotides 7093 to 7344 of CaMV DNA, the linker sequence CATCGATG, nucleotides 7093 to 7439 of CaMV, the linker sequence GGGGACTCTAGAGGATCCAG (SEQ. ID. NO.
- nucleotides 167 to 186 of MSV nucleotides 188 to 277 of MSV, a C residue followed by nucleotides 119 to 209 of Adhl.S, nucleotides 555 to 672 of maize Adhl.S, the linker sequence
- nucleotide 317 of MSV (including the EcoR I site) . It is noteworthy that the junction between nucleotide 317 of MSV and the long polylmker sequence creates an Nco I recognition site.
- DNA of plasmid pDAB303 was digested with Nco I and Sac I, and the 3939 bp fragment was ligated to the 1866 bp fragment containing the GUS coding region prepared from similarly digested DNA of pKA882.
- the appropriate plasmid was identified by restriction enzyme site mapping, and was named pDAB305. This plasmid has the enhanced promoter, MSV leader and Adhl mtron arranqement of pDAB303, positioned to control expression of the GUS gene.
- DNA of plasmid pKA882 was digested with Xba I and Nco I and the 5687 bp fragment was ligated to annealed syntnetic oligonucleotides having the sequence CTAGAGGATC (SEQ. ID. NO. 66) and CATGGATCCT (SEQ. ID. NO. 67) . These oligonucleotides when annealed form a double- stranded structure having Xba I- and Nco I-compatible sticky ends.
- a recombinant plasmid lacking a Sal I site was identified by restriction enzyme mapping, verified by DNA sequence analysis, and was named pDAB349.
- DNA of plasmid p35S En 2 /NOS was digested with Xba I and EcoR I, and the large fragment (3287 bp) was ligated to a 2152 bp fragment containing the GUS coding region and NOS polyadenylation region from similarly-digested pDAB349.
- a plasmid having the appropriate structure was identified by restriction site mapping, and was named pDAB313.
- DNA of plasmid pDAB313 was digested with Xba I and Sac I, and the large 3558 bp fragment was ligated to a
- DNA of plasmid pDAB348 was digested with BamH I, and the large fragment (5437 bp) was ligated to a 213 bp Bel I/BamH I fragment containing the deleted version of the Adhl.S mtron 1, from pSG AdhAl ⁇ (Example 7D Step 2).
- a plasmid having the appropriate structure was identified by restriction site mapping and was named pDAB353.
- the starting material is plasmid pIC35.
- This plasmid contains the 845 bp Sma I/ Hmd III fragment from pUC13 35S (-343) (see Section C of this example) , ligated into the Nru I and Hind III sites of pIC19R (Marsh et al., Gene, 32 (1984) 481), in the orientation such that the Hind III recognition site is maintained.
- the source of the A. tumefaci ens ORF25/26 sequences is plasmid pICl925.
- This plasmid contains the 713 bp Hinc II fragment comprised by nucleotides 21728 to 22440 of A .
- tumefaci ens pTi 15955 T-DNA (Barker et al., Plant Molec. Biol. 2 (1983) 335), ligated into the Sma I site of pIC19H (Marsh et al., Gene, 32 (1984) 481), in the orientation such that the BamH I site of pIC19H is adjacent to the ORF 25 end of the T-DNA fragment.
- pIC 19R35/A DNA of plasmid pIC35 was digested with BamH I, and ligated to the 738 bp fragment prepared by digestion of pIC1925 DNA with BamH I and Bgl II. An E. coli transformant was identified that harbored a plasmid in which a BamH I site was present positioned between the 35S promoter fragment, and the ORF 25/26 Poly A fragment. This plasmid was named pIC 19R35/A. (Note: Ligation of the compatible sticky ends generated by BamH I and Bgl II generates a sequence that is not a recognition site for either enzyme.)
- pIC35/A DNA of pIC 19R35/A was digested with Sma I at its unique site, and the DNA was ligated to Bgl II linkers having the sequence CAGATCTG. [NOTE: The tandomization of these Bgl II linkers generates, besides Bgl II recognition sites, also Pst I recognition sites, CTGCAG] . An E. coli transformant was identified that had at least two copies of the linkers (and therefore new Bgl TJ and Pst I sites) at the position of the former Sma I site. This plasmid was named pIC35/A.
- pIC 20R ⁇ DNA of plasmid pIC 20R (Marsh et al . , Gene, 32 (1984) 481) was digested with Nru I and Sma I, and the blunt ends of the large fragment were ligated together. An E. coli transformant was identified that harbored a plasmid that lacked Nru I, Sma I, Hmd III, Sph I, Ps t I, Sal I, Xba I, and BamH I sites. This plasmid was called pIC 20R ⁇ .
- pSG Bgl 3525 (Pst) DNA of pIC 20R ⁇ was digeste ⁇ with Bgl II, and was ligated to the 1625 bp Bgl II fragment of pIC35/A.
- An E. coli transformant was identified that harbored a plasmid that contained the 35S promoter/ORF 25 poly A sequences. Restriction enzyme site mapping revealed these sequences to be m the orientation such that the unique Kpn I and Xho I sites of pIC 20R ⁇ are positioned at the 3' end of the ORF 25 Poly A sequences. This plasmid was named pSG Bgl 3525 (Pst) .
- pSG 3525 a DNA of pSG Bgl 3525 (Pst) was digested with Bgl II under conditions in which only one of the two Bgl II sites of the molecule were cleaved.
- the 4301 bp linear fragments were ligated to synthetic adapter oligonucleotides having the sequence GATCGTGA TCAC (SEQ. ID. NO. 68) , where the underlined bases represent the Bel I recognition sequence.
- An E. coli transformant was identified that had a Bel I site at the position of the former Bgl II site positioned 5' to the 35S promoter. This plasmid was named pSG 3525 a (Pst) .
- pDAB 218 DNA of plasmid pIJ4104 (see Example 8) was digested with Sma I, and the 569 bp fragment was purified from an agarose gel. DNA of plasmid pSG 3525 a (Pst) (see above) was linearized by digestion at the unique Hmc II that lies between the 35S promoter and ORF 25 poly A sequences, and the linear fragment was ligated to tne 569 bp bar gene fragment. An E . coli transformant was identified by restriction enzyme site mapping that harbored a plasmid that contained the jbar gene in the orientation such that Bgl II digestion generated fragments of 4118 and 764 bp.
- This plasmid was name ⁇ pDAB 218. ⁇ ⁇ . pDAB 219: DNA of plasmid pDAB 218 was digested with Bel I, and the linear fragment of 4882 bp was ligated to a 3133 bp Bgl II fragment prepared from DNA of pKA882- 2xBg (see step 10 below) . The latter fragment contains the GUS coding region, under the transcriptional control of the 35S promoter, with the Nos Poly A transcription termination signals. An __. coli transformant was identified that contained the GUS and PAT coding regions, and restriction enzyme recognition site mapping revealed that both coding regions were encoded by the same DNA strand. This plasmid was named pDAB 219.
- DNA of plasmid pDAB 219 was used as the template for the polymerase chain reaction (PCR, (Saiki et al., Science, 239 (1988) 487) ) using as primers the synthetic oligonucleotides: l) CTCGAGATCTAGATATCGATGAATTCCC (SEQ.
- Primer l represents nucleotides 419 to 446 of pDAB
- the single underlined bases in Primer n) represent the recognition sequence of BamH I, and the double underlined oases represent nucleotides 1138 to 1159 of pDAB 219, and correspond to nucleotides 21728 to 21749 of the ORF 25
- pKA882-Bg pKA882 DNA was digested with Pst I, and the linear fragments were ligated to synthetic adaptors having the sequence CAGATCT GTGCA (SEQ. ID. NO. 71) (Note: When annealed, these molecules form double stranded molecules that have sticky ends compatible with those generated by Pst I. Ligation of such molecules to Ps t I digested DNA results in a sequence that is no longer cleaved by Pst I, and introduces a new Bgl II site.) .
- An E . coli transformant was identified that harbored a plasmid that was not cleaved by Pst I, a criz that had a unique Bgl II site. The plasmid was name: pKA882-Bg.
- pKA882-2xBg DNA was digested with EcoR I, and the linear fragments were ligated to synthetic adaptors having the sequence AATTGAGATCTC (SEQ. ID. NO. 72) . Ligation of annealed such molecules to EcoR I digested DNA results m a sequence that is no longer cleaved by EcoR I, and introduces a new Bgl II site. An E. coli transformant was identified that harbored a plasmid that was not cleaved by EcoR I, and that generated Bgl II fragments of 3027 and 2658 bp. This plasmid was named pKA882-2xBg.
- pDAB 305 Bg Plasmid pDAB305 was digested to completion with EcoR I, and the linearized DNA was ligated to kmased, self-complementary oligonucleotide adapters having the sequence AATTGAGATCTC (SEQ. ID. NO. 73) . Ligation of this adapter to the overhanging ends generated by EcoR I recircularized the plasmid DNA, introduced a new Bgl II recognition site, and destroyed the former EcoR I recognition site. The resulting plasmid was named pDAB 305 Bg.
- EXAMPLE 8 Construction of plant transformation vectors containing the bar gene of Streptomyces hygroscopi cus
- the starting material is plasmid pIJ4104 (White et aL., Nucl. Acid Res. 18 (1990) 1062) , which contains the coding region of the bar gene of S . hygroscopi cus, and was obtained from M.J. Bibb (John Innes Institute, Norwich, United Kingdom) .
- the bar gene encodes the enzyme phosphmothricm acetyl transferase (PAT) .
- pDAB 219 ⁇ DNA of plasmid pDAB 219 was digested with Bgl II, the 7252 bp fragment was purified from an agarose gel, and ligated to the 747 bp fragirent generated by digestion of the PCR product of Example F Step 8 by Bgl II and BamH I .
- An E . coli transformart was identified that harbored a plasmid that contained a unique Bgl II site positioned at the 3' end of the ORF 25 Poly A fragment. The DNA structure of the 3' end of the PAT coding sequence was confirmed by DNA sequence analysis. This plasmid was named pDAB 219 ⁇ .
- the DNA sequence of pDAB 219 ⁇ is as follows: Beginning with the base following the last A residue of the Xba I site on the lac Z coding strand of pIC20R (Marsh et al., Gene, 32 (1984) 481) , the linker TCCTGATCTGTGCA GGTCCCC (SEQ. ID. NO. 74), followed by CaMV nucleotides 6605 to 7439, followed by the linker sequence GGGGACTCTAGAGGATCCGGATCCGTCGACCATGGTC (SEQ. ID. NO. 75), followed by the rest of the coding region of GUS with 44 bp of 3' flanking E. coli genomic DNA (nucleotides 306 to 2152 of Jefferson et al .
- the underlined bases represent the codons for the first two ammo acids of the GUS protein, the second of which was changed from leucine m the original E. coli uid A gene (Jefferson et al . , (Proc. Natl. Acad. Sci., 83 (1986) 8447) to valine m pRAJ275 (Jefferson et al., Plant Molec. Biol, Reporter, 5 (1987) 387) . These bases are followed by the linker sequence GGGGAATTGGAGAGCTCGAATTTCCCC (SEQ. ID. NO.
- the Bt ICP gene was subcloned into three different vectors.
- the ICP gene was cloned plasmid pDAB305Bg.
- the BamH I site situated downstream of the ICP gene was modified to a Ss t I site by insertion of a BamH I/ Ss t I adapter.
- the 1854 base pair Nco I-Sst I fragment carrying the ICP gene was inserted under the control of the high expression doubly enhanced 35S promoter and the nopalme synthase (Nos) poly A addition sequences, resulting m plasmid pDAB910 ( Figure 6) .
- the enhanced 35S/Bt/Nos cassette was subcloned from pDAB910, as a 3150 base pair Bgl II fragment, into the unique Bgl II site of pDABl99, where the preparation of this plasmid is disclosed Sukhapmda et al. (Plant Cell Reports 13 (1993) 63) , transformation of maize (Zea maysl) proplasts and regeneration resulting m plasmid pDAB911 ( Figure 7) .
- EXAMPLE 9 Construction of a Reference Gene Encoding Firefly Luciferase.
- GUS protein Production of the GUS protein from genes controlled by different promoter versions was often compared relative to an internal control gene that produce ⁇ firefly luciferase (DeWet et al., Molec. Cell Biol. 7 (1987) 725) .
- a plasmid (pT3/T7-l LUC) containing the luciferase (LUC) coding region was purchased from CLONTECH (Palo Alto, CA) , and the coding region was modified at its 5' ana 3' ends by standard methods. Briefly, the sequences surrounding the translational start (ATG) codon were modified to include an Nco I site (CCATGG) and an alanme codon (GCA) at the second position.
- CCATGG Nco I site
- GCA alanme codon
- an Ssp I recognition site positioned 42 bp downstream of the Stop codon of the luciferase coding region was made blunt ended with T4 DNA polymerase, and ligated to synthetic oligonucleotide linkers encoding the Bgl II recognition sequence.
- These modifications permit the isolation of the intact luciferase coding region on a 1702 bp fragment following digestion by Nco I and Bgl II. This fragment was used to replace the GUS gene of plasmid pDAB305 (see Example 7E, step 5) , such that the luciferase coding region was expressed from the enhanced 35S promoter, resulting in plasmid pDeLux.
- the 5' untranslated leader of the primary transcript includes the modified MSV leader/Adh mtron sequence.
- microspore-derived (MSD) cultures were used as the starting plant materials. These microspore-derived (MSD) cultures were maintained as described by Mitchell et al., J. Plant Physioi . , 137 (1991) 530. The cultures are haploid, and some cell lines were capable of regenerating haploid plants. Eight- to 20-month old cell suspension cultures were used for protoplast isolation.
- the protoplast density was adjusted to 4 x 10 r protoplasts/ml of electroporation solution [20 mg/L KH..P0 4 , 115 mg/L NaH 2 PO place, 444 mg/L CaCl 2 , 7.5 g/L NaCl, 36.4 g/L mannitol, pH 7.2 (Fromm et al., Nature, 319 (1986) 791] .
- the protoplast suspension was heat shocked at 42°C for 5 minutes and then placed on ice.
- the plasmids pDAB 911 alone or pDAB 910 together with pDAB 326 were used in the protoplast transformation experiments.
- Equimolar DNA amounts of the plasmids e.g.
- pDAB 911 64 ⁇ g of pDAB 911, 31.6 ⁇ g of pDAB 910 and 46 ⁇ g of pDAB 326) were used.
- the plasmid DNA m 2 r ⁇ -40 ⁇ l sterile 1.0 mM Tris, pH 8.0, 1.0 mM EDTA, was place ⁇ in a one ml polystyrene electroporation cuvette containing a volume of the electroporation solution to make a total volume of 0.5 ml.
- One-half ml of the protoplast suspension was pipetted into the cuvette immediately before a single electrical pulse (400 ⁇ F, 300 v/cm) was applied from an IBI Gene Zapper unit. The cuvette was immediately placed on ice for 10 minutes.
- a volume of two hundred and fifty ⁇ l of the protoplast suspension (ca. 5 x 10 5 protoplasts) was spread on a filter (47 mm nylon; Micron Separations, Inc.) whic. was placed over the feeder cells (300 mg of MSD cells, Line 34) spread over Ml solid medium m a 60 x 15 mm polystyrene Petri plate.
- tre filter was transferred to a selection medium containing 100 mg/L kanamyem sulfate. After four to six weeks on the kanamyem containing medium, resistant callus isolates could be observed and selected. From a total of four transformation experiments with the mentioned plasmids, over 400 isolates were selected. These callus isolates were grown on the same medium until enough tissue was accumulated for further analysis.
- Embryogenic callus cultures were initiated from immature embryos of genotypes specially bred for amenability to m vi tro manipulation. Cultures representing two genotypes were used: I) "Backcrossed B73” is a BC j inbred derived from the cross B73-. (B73xA188) , and n) "High II” is a hybrid made by mtermatmg two S 3 lines derived from a B73xA188 cross. When exposed to appropriate cultural conditions, immature embryos from both of these genotypes display consistently high levels of callus formation capable of fertile plant regeneration.
- Seeds of the two S 3 parents of "High II" and B73 were sown individually m pots containing approximately 4 kg of dry soil mix #3 (Conrad Fafard, Inc., Springfield, MA) moistened and adjusted to pH 6.0.
- the plants were maintained in a greenhouse under a 16/8 photoperiod.
- Ambient daylight was supplemented with a combination of high pressure sodium and metal halide lamps such that the minimum light intensity 2 above pot level was approximately 1,500 ft-candles.
- Greenhouse temperature was maintained within 3°C of 28°C during the day and 22°C at night.
- the plants were irrigated as needed with a solution containing 400 mg/L of 20-20-20 fertilizer (W.R. Grace & Co . , Fogelsville, PA) , plus 8 mg/L chelated iron (CIBA-GEIGY, Greensboro, NC) .
- the ear was excised and surface sterilized by emersion in 70% v/v ethanol for 10 minutes followed by soaking m 20' v/v commercial bleach (1% sodium hypochlorite) for 30 minutes. Following a sterile, distilled water rinse, immature embryos were aseptically isolated and placed onto an "initiation" medium with the embryo axis m contact with the medium (scutellar-side away from the medium) .
- the "initiation" medium consisted of the following components: N6 basal salts and vitamins (Chu, Proc. Symp. Plant Tissue Culture, (1978), Peking Press, pp.
- the immature embryos were incubated at 28°C m the dark for 10-30 days during which time callus tissue, displaying various types of morphology, proliferated from the scutellar region.
- the callus tissue produced during this time was classified into three distinct types: i) soft, granular, translucent callus lacking any apparent morphological organization (known as nonembrogenic) , n) compact, nodular, yellowish-to-white callus consisting of groups of somatic embryos (often fused) with distinct scutellar- and coleoptile-like structures (known as Type I), and in) soft callus with numerous globular and elongated somatic embryos on suspensor-like structures (known as Type II) .
- Type II callus was the most suitable for establishing friable, embryogenic cultures.
- Helium blasting involved accelerating micron- size particles, coated with plasmid DNA, to penetrating velocities.
- the device used was described m U.S. Patent No. 5,141,131. Briefly, the device consisted of a high pressure helium source, a reservoir of DNA-coated gold microparticles m suspension, and a multipurpose valve which provided selective communication between the outlet of the helium source and the inlet of the gold suspension.
- the gold particles were coated with plasmid DNA (pDAB917) containing coding sequences for selectable and screenable marker genes.
- the selectable marker gene was bar which enco ⁇ es for the enzyme phosph othricm acetyltransferase (PAT) and confers resistance to the herbicide Basta ' " .
- the screenable marker gene was ui dA which encodes for ⁇ - glueuronidase (GUS) , the activity of which was monitored histochemically. Both genes were driven by the 35S constitutive promoter from Cauliflower Mosaic Virus. In this way, rare transformed cells were selected out of a background of non-transformed tissue by exposure to the herbicide Basta 1* and tested for the presence of ⁇ - glueuronidase activity using a histochemical assay which turned positive tissue blue.
- Plasmid DNA was adsorbed onto the surface of gold particles prior to use m transformation experiments.
- the gold particles were spherical with diameters ranging from about 1.5-3.0 microns (Aldrich Chemical Co., Milwaukee, WI). Adsorption was accomplished by adding 74 uL of 2.5 M calcium chloride and 30 uL of 0.1 M spermidme to 300 uL of DNA/gold suspension (140 ug pDAB917, 0.01 M Tris buffer, and ImM EDTA) .
- the DNA-coated gold particles were vortexed immediately, then allowed to settle to the bottom of an Eppendorf tube and the resultant clear liquid was completely drawn off.
- the DNA-coated gold particles were then resuspended m 1 mL of 100% ethanol. The suspension was then diluted to 15 mg DNA/gold per mL of ethanol for use m helium blasting experiments.
- the tissue was allowed to dry out slightly by allowing the plates to stand uncovered m a laminar flow hood for several minutes before use.
- the callus was covered with a 104 micron stainless steel screen.
- the DNA-coated gold particles were then accelerated at the callus tissue. Each callus tissue sample was blasted 10-15 times with each blast delivering approximately 1 uL of DNA-coated gold suspension.
- callus tissue was allowed to incubate for 1-2 days under the conditions described previously. Each tissue sample was then divided into approximately 60 equal pieces (1-3 mm diameter) and transferred to fresh "maintenance" medium containing 30 mg/L Basta 11 '. Every three weeks, callus tissue was non- selectively transferred (with no regard for tissue morphology) to fresh Basta ⁇ -conta mg "maintenance” medium. At this concentration of herbicide, very little growth occurred. After 8-16 weeks, sectors proliferating from a background of growth inhibited tissue were apparent. This tissue was isolated from the other callus and maintained separately on Basta ⁇ -contammg
- All Basta m -res ⁇ stant callus (whether GUS positive or GUS negative) was selectively subcultured to "induction" medium and incubated at 28°C m low light (125 ft-candles) for one week followed by one week m high light (325 ft-candles) provided by cool fluorescent lamps.
- the "induction" medium was composed of MS salts and vitamins (Murashige et al. , Physiol. Plant, 15 (1962) 473-497) 30 g/L sucrose, 100 mg/L myo-mositol, 5 mg/L benzyl-ammo purme, 0.025 mg/L 2,4-D, 2.5 g/L gelrite adjusted to pH 5.7. Following this two-week induction period, the callus was then non-selectively transferred to "regeneration" medium and incubated high light at 28°C.
- the "regeneration” medium was composed of MS salts and vitamins, 30 g/L sucrose, and 2.5 g/L gelrite adjusted to pH 5.7. Every 14-21 days the callus was subcultured to fresh "regeneration” medium selecting for tissue which appeared to be differentiating leaves and roots. Both "induction” and “regeneration” media contained 30 mg/L BastaTM. Plantlets were transferred to 10 cm pots containing approximately 0.1 kg of dry soil mix, and were then moistened thoroughly and covered with clear plastic cups for approximately 4 days. At the 3-5 leaf stage, plants were transplanted to larger pots and grown to maturity as previously described. Self- or siblmg-pollmations were performed on plants regenerated from the same culture or crossed to non-transformed seed- derived plants m order to obtain transgenic progenies.
- transgenic progency described m Example 11 Using the procedures and transgenic progency described m Example 11, four (4) transgenic mbreds were prepared using conventional breeding techniques. The resulting mbreds were used to develop four transgenic hybrids .
- Second generation European Corn Bore was evaluated at all locations.
- First generation ECB and corn earworm were evaluated only at the Indiana and Illinois field research stations. All insects were obtained from a single source. Each trial was infested twice (4-6 days apart) with neonate larvae. For first generation ECB studies, 40-80 larvae were applied to plants at the mid-whorl development stage, while the same number of larvae were applied at mid-silk stage m second generation ECB studies. Damage to plants was determined 6 weeks later by splitting stalks and ear shoots when present. Number of ECB larvae and tunnels were recorded for each of 10 plants per replicate. Studies on corn earworm required 10 plants per replicate to be artificially infested with first mstar larvae of corn earworm at about 5-10 per ear. Approximately 3 weeks later, ears were evaluated for the number of larvae present.
- Black Mexican Sweet (BMS) cultures (V. Walbot, Stanford University) were maintained as suspensions m liquid medium (From et al., PNAS USA 82 (1985) 351) .
- Protoplasts were isolated from 4-day old cultures by suspending the cells in 4X volumes of protoplast isolation solution (Fromm et al., Enzymol . 153 (1987) 351) containing 0.5% cellulase Onozuka RS, 0.5% hemicellulase, 0.02% pectmase (Karlan Research Products, Santa Rosa, CA) , followed by gentle shaking.
- DNA mixtures contained (per 2 x 10° protoplasts m 1 ml) , 60 ug of test plasmid DNA and 4.5 ug of reference plasmid DNA.
- Electroporation conditions were: 1500 uF, 200-400V across a 1 cm gap, pulse time of 25 msec (Promega Model 240/250, Madison, WI) . Following electroporation, the protoplasts were placed on ice for 10 mm, then plated into plastic Petri dishes (previously coated with a thm layer of 1.2% SeaPlaque agarose; FMS BioProducts, Rockland, ME) containing protoplast growth medium (Fromm et al . , PNAS USA 82 (1985) 351) at a density of 2.5 x 10 5 protoplasts/ml.
- Fluorometric assays for GUS activity using 4- methyl-umbelliferyl-glucuronide as a substrate were essentially as described by Jefferson (Plant Molec. Biol. Reporter 5 (1987) 387) , and assays for luciferase activity using lucife ⁇ n as substrate were based on the methods of DeWet et al. (Molec. Cell. Biol. 7 (1987)
- This example describes the cloning of mtron 6 of the maize Adhl.S gene and its incorporation into the synthetic 5' untranslated leader sequence derived from the Maize Streak Virus coat protein gene (MSV/CPL, see above) .
- the starting material is plasmid pB428, obtained from J. Bennetson, Purdue University. This is a clone if ab 11.5 kbp BamH I fragment of maize genomic DNA inserted into tne BamH I site of pBR322, and containing the Adhl.S gene (Dennis et al., Nucl. Acids Res. 12 (1984) 3983) .
- a 396 bp fragment containing the mtron 6 sequence and parts of flanking exons 6 and 7 was amplified from 10 ng of pB428 template DNA using 100 pmol each of forward primers having the sequence CGACCTGATCACCCCAGCAGATTCGAAGAAGG (SEQ. ID. NO.
- primers contain the recognition sequences for Bel I (TGATCA, underlined m forward primer), and BamH I, (GGATCC, underlined reverse primers) . They are designed to introduce the Be I site immediately before nucleotide 2162, and the BamH I site immediately following nucleotide 2534, of the Adhl.S sequence of Dennis et al . (Nucl. Acids Res. 12 (1984) 3983) .
- the resulting PCR fragment contains 20 bases of Adhl.S exon 6, all of mtron 6, and 11 bases of exon 7, as presented (SEQ. ID. N,0. 83)
- Reactions 100 ul final volume contained, besides template and primers, 1 x PCR reaction buffer (as described m Example 2), 0.2 mM final concentration of dATP, dTTP, dGTP, and dCTP, and 5 units of Taq DNA polymerase (Perkm Elmer/Cetus) .
- Temperature cycles were: 94° (1 mm; 25 cycles of 94° (1 mm), 55° (30 sec), 72° (30 sec), followed by an extension period of 72°, 10 mm.
- pCPL- Adh6 Appropriate-sized fragments were extracted from an agarose gel, digested with restriction enzymes Bel I and BamH I, and ligated into Bgl II-d ⁇ gested DNA of pCPL-Bg (see above) .
- a plasmid was identified that had an appropriate restriction enzyme map, and was named pCPL- Adh6.
- pCPL-Adh6 The structure of pCPL-Adh6 is as follows (vector sequences of pBSK are not included, see Examp_e 7C step 1) : the linker sequence GGATCCAG that includes a BamH I recognition site, nucleotides 167 to 186 of MSV, nucleotides 188 to 277 of MSV, the linker sequence GATCA, nucleotides 2162 to 2534 of maize Adhl.S, the linker sequence GGATCTG, and finally nucleotides 278 to 317 of MSV, including an Nco I recognition sequence (SEQ. ID. NO. 84) .
- the MSV leader/mtron sequences can be obtained from this plasmid by digestion with BamH I and Nco I, and purification of the 541 bp fragment. This fragment is therefore the functional equivalent of the analogous fragment containing the Adhl.S mtron 1 fragment ut ⁇ _ ⁇ zed m palsmids described m Examples 7 and 13.
- nucleotide sequence coding for an msecticial protein from Bt having the nucleotide SEQ. ID. NO. 1 and ammo acid SEQ. ID. NO. 2 is shown m Table 22.
- ATC AAC QM_ TOD ATC CCT T*C AAC TOC TT ⁇ AOC AAC CCT Q» OTB «_»Q Cm CU OBT O0T OMJ CCE ATT OW A.»
- Aan Aan P e Aan lla Aan Mu Qra lla Pre T r Aan Cya Uu bl Aan Pre Ola Ml 0> WI Uu Mr Olr Olu A i g lla Mu
- Trg Olr Pha Aag Ala Ala Thr lla Aan Mr Arg T r Aan Aag Uu Thr Arg Uu lla Mr Aan r Thr Aag Trr Ala WI Arg Trg
- AOC ATT OT TCT CCT CM? CTO ATO WC ATT CTT 271 Pra WI Uu Mu Aan Phi teg Oly Mr Pha Arg My Mr Ala Mn Mr lla Mu Arg Mr lla Arg Mr Pra Ma Uu Mil teg lla Uu 901 ;
- AGC ATC ART ATC TAC AM «VC OCT CM? OO- C_E TAO TAC TAC TOO TCT OtE CM5 CAA
- TAC TTC CM TOO C ⁇ C AM «CT TTC MX: ACC TCT CTT ⁇ c A O ATC om TOT c ⁇ o etc AM: TTC T ⁇ .T ere fen GOT COT T- .
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Insects & Arthropods (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Catching Or Destruction (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US540595P | 1995-10-13 | 1995-10-13 | |
US5405P | 1995-10-13 | ||
PCT/US1996/016582 WO1997013402A1 (fr) | 1995-10-13 | 1996-10-11 | Gene modifie de bacillus thuringiensis pour combattre les lepidopteres sur les plantes |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0861021A1 true EP0861021A1 (fr) | 1998-09-02 |
EP0861021A4 EP0861021A4 (fr) | 2005-01-12 |
EP0861021B1 EP0861021B1 (fr) | 2009-09-23 |
Family
ID=21715689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96936576A Expired - Lifetime EP0861021B1 (fr) | 1995-10-13 | 1996-10-11 | Gene modifie de bacillus thuringiensis pour combattre les lepidopteres sur les plantes |
Country Status (13)
Country | Link |
---|---|
US (1) | US6166302A (fr) |
EP (1) | EP0861021B1 (fr) |
JP (1) | JP4030582B2 (fr) |
CN (1) | CN1176577C (fr) |
AT (1) | ATE443437T1 (fr) |
AU (1) | AU708256B2 (fr) |
BR (1) | BR9611000A (fr) |
CA (1) | CA2234656C (fr) |
DE (1) | DE69638032D1 (fr) |
ES (1) | ES2330168T3 (fr) |
IL (1) | IL124020A (fr) |
RU (1) | RU2224795C2 (fr) |
WO (1) | WO1997013402A1 (fr) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999002694A1 (fr) * | 1997-07-09 | 1999-01-21 | The University Of Queensland | Sequence d'acides nucleiques et procede pour exprimer, de maniere selective, une proteine dans une cellule ou un tissu cible |
US5874288A (en) | 1997-07-31 | 1999-02-23 | Mycogen Corporation | Bacillus thuringiensis toxins with improved activity |
JPH1175845A (ja) * | 1997-09-01 | 1999-03-23 | Norin Suisansyo Tohoku Nogyo Shikenjo | トリプシンインヒビターの人工合成遺伝子 |
US6218188B1 (en) * | 1997-11-12 | 2001-04-17 | Mycogen Corporation | Plant-optimized genes encoding pesticidal toxins |
AUPP058797A0 (en) * | 1997-11-28 | 1997-12-18 | Commonwealth Scientific And Industrial Research Organisation | Novel gene |
US6060594A (en) | 1997-12-18 | 2000-05-09 | Ecogen, Inc. | Nucleic acid segments encoding modified bacillus thuringiensis coleopteran-toxic crystal proteins |
GR1008462B (el) * | 1998-01-16 | 2015-04-08 | Novartis Ag, | Χρηση νεονικοτινοειδων στον ελεγχο ζιζανιων |
PT1054985E (pt) | 1998-02-20 | 2012-07-03 | Syngenta Ltd | Produção de semente híbrida |
ES2328427T3 (es) | 1998-03-30 | 2009-11-12 | Dow Agrosciences Llc | Modificacion de la composicion de acido graso en plantas mediante la expresion de una delta-9 coa desaturasa de aspergillus nidulans. |
ATE506441T1 (de) * | 1998-08-19 | 2011-05-15 | Monsanto Technology Llc | Pflanzliche expressionsvektoren |
KR20010073216A (ko) | 1998-10-23 | 2001-07-31 | 칼튼 제이. 에이블 | 약 15kDa 및 약 45kDa 살충성 단백질을 코딩하는식물에 최적화된 폴리뉴클레오티드 |
NL1010976C2 (nl) * | 1999-01-06 | 2000-07-07 | Avebe Coop Verkoop Prod | Het scheiden en winnen van componenten uit planten. |
AR025097A1 (es) * | 1999-08-11 | 2002-11-06 | Dow Agrosciences Llc | Plantas transgenicas expresando la toxina photorhabdus |
US6501009B1 (en) | 1999-08-19 | 2002-12-31 | Monsanto Technology Llc | Expression of Cry3B insecticidal protein in plants |
CA2486543A1 (fr) | 2002-06-28 | 2004-01-08 | Dow Agrosciences Llc | Proteines d'action pesticide et polynucleotides obtenus a partir d'especes paenibacilles |
PL1620571T3 (pl) | 2003-05-02 | 2015-10-30 | Dow Agrosciences Llc | Zdarzenie kukurydzy TC1507 i sposoby jego wykrywania |
US20060282917A1 (en) * | 2003-05-22 | 2006-12-14 | Syngenta Participations Ag | Modified starch, uses, methods for production thereof |
EP2308976B2 (fr) | 2004-04-30 | 2017-05-10 | Dow AgroSciences LLC | Nouveau gène de résistance aux herbicides |
CA2584960A1 (fr) | 2004-10-21 | 2006-05-04 | Charles L. Niblett | Procedes et materiaux permettant de conferer a des plantes une resistance aux parasites et aux agents pathogenes |
ES2637948T3 (es) | 2005-10-28 | 2017-10-18 | Dow Agrosciences Llc | Nuevos genes de resistencia a herbicidas |
WO2007098042A2 (fr) * | 2006-02-17 | 2007-08-30 | Monsanto Technology Llc | Séquences régulatrices chimériques qui comprennent des introns pour l'expression d'un gène de plante |
CN100420751C (zh) * | 2006-02-27 | 2008-09-24 | 浙江大学 | 一种杀虫基因及其用途 |
NZ581361A (en) | 2007-05-09 | 2012-11-30 | Dow Agrosciences Llc | Transgenic plants that comprise proteins with aryloxyalkanoate dioxygenase activity |
WO2009048966A2 (fr) * | 2007-10-08 | 2009-04-16 | Monsanto Technology Llc | Promoteurs dicotylédones modifiés capables de s'exprimer dans des végétaux monocotylédones |
WO2009151748A1 (fr) * | 2008-06-11 | 2009-12-17 | Pioneer Hi-Bred International, Inc. | Nouveau gène de bacillus thuringiensis avec activité anti-lépidoptère |
EP2199399A1 (fr) * | 2008-12-17 | 2010-06-23 | BASF Plant Science GmbH | Production de cétocaroténoïdes dans les plantes |
WO2010079032A1 (fr) * | 2008-12-17 | 2010-07-15 | Basf Plant Science Gmbh | Production de cétocaroténoïdes dans des plantes |
WO2010108114A2 (fr) | 2009-03-19 | 2010-09-23 | Martek Biosciences Corporation | Molécules d'acide nucléique et polypeptides d'acide gras polyinsaturé synthase, compositions, et procédés de préparation et utilisations de ceux-ci |
BRPI1015333A2 (pt) | 2009-04-17 | 2016-05-24 | Dow Agrosciences Llc | "toxinas cry inseticidas dig-3" |
RU2593961C2 (ru) | 2009-12-16 | 2016-08-10 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | КОМБИНИРОВАННОЕ ПРИМЕНЕНИЕ БЕЛКОВ CRY1Ca И CRY1Fa ДЛЯ БОРЬБЫ С РЕЗИСТЕНТНОСТЬЮ У НАСЕКОМЫХ |
US9234208B1 (en) * | 2010-05-10 | 2016-01-12 | Dow Agrosciences Llc | DIG-13 insecticidal cry toxins |
BR112012033112A2 (pt) | 2010-06-24 | 2015-09-08 | Dow Agrosciences Llc | redução do teor de ácidos graxos saturados de sementes de planta. |
CN103269577B (zh) | 2010-07-29 | 2017-12-26 | 陶氏益农公司 | 经修饰以增加植物转化频率的土壤杆菌属的菌株 |
AU2011296212B2 (en) | 2010-08-30 | 2015-06-11 | Dow Agrosciences Llc | Activation tagging platform for maize, and resultant tagged population and plants |
WO2012074868A2 (fr) | 2010-12-03 | 2012-06-07 | Ms Technologies, Llc | Expression optimisée de molécules d'acide nucléique codant pour la résistance au glyphosate dans cellules végétales |
AR087888A1 (es) | 2011-09-14 | 2014-04-23 | Dow Agrosciences Llc | Plantas con caracteristicas relacionadas al estres y metodos para producirlas |
US20140075593A1 (en) | 2012-09-07 | 2014-03-13 | Dow Agrosciences Llc | Fluorescence activated cell sorting (facs) enrichment to generate plants |
RU2016116914A (ru) | 2013-10-04 | 2017-11-13 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Регуляторные элементы гена металлотионеин-подобного белка из zea mays и их применение |
BR102014025499A2 (pt) | 2013-10-15 | 2015-09-29 | Dow Agrosciences Llc | elementos regulatórios de zea mays e uso dos mesmos |
BR102014025574A2 (pt) | 2013-10-15 | 2015-09-29 | Dow Agrosciences Llc | elementos regulatórios de zea mays e usos dos mesmos |
TW201525136A (zh) | 2013-11-26 | 2015-07-01 | Dow Agrosciences Llc | 利用破囊壺菌PUFA合成酶於油籽作物中生成ω-3長鏈多不飽和脂肪酸 |
CN111793640A (zh) | 2013-12-06 | 2020-10-20 | 奥驰亚客户服务公司 | 烟草植物及使用此类植物的方法 |
TW201527312A (zh) | 2013-12-31 | 2015-07-16 | Dow Agrosciences Llc | 新穎玉米泛素啓動子(一) |
TW201527313A (zh) | 2013-12-31 | 2015-07-16 | Dow Agrosciences Llc | 新穎玉米泛素啓動子(二) |
TW201527314A (zh) | 2013-12-31 | 2015-07-16 | Dow Agrosciences Llc | 新穎玉米泛素啓動子(三) |
TW201527316A (zh) | 2013-12-31 | 2015-07-16 | Dow Agrosciences Llc | 新穎玉米泛素啓動子(五) |
BR102015000943A2 (pt) | 2014-01-17 | 2016-06-07 | Dow Agrosciences Llc | expressão aumentada de proteína em planta |
TW201538518A (zh) | 2014-02-28 | 2015-10-16 | Dow Agrosciences Llc | 藉由嵌合基因調控元件所賦予之根部特異性表現 |
MX2016015857A (es) | 2014-06-20 | 2017-03-20 | Dow Agrosciences Llc | Proteinas insecticidas vegetativas utiles para controlar plagas de insectos. |
WO2016004193A1 (fr) | 2014-07-02 | 2016-01-07 | Altria Client Services Llc | Tabac dont les feuilles possèdent des propriétés modifiées et procédés de fabrication et d'utilisation |
WO2016007632A1 (fr) | 2014-07-08 | 2016-01-14 | Altria Client Services Llc | Locus génétique à l'origine d'un faible caractère anatabine chez le tabac et ses procédés d'utilisation |
JP6702957B2 (ja) | 2014-10-06 | 2020-06-03 | アルトリア クライアント サービシーズ リミテッド ライアビリティ カンパニー | タバコ植物における腋芽成長の遺伝的制御法 |
CN114213511A (zh) | 2014-12-30 | 2022-03-22 | 美国陶氏益农公司 | 可用于控制昆虫害虫的修饰的Cry1Ca毒素 |
MX2017012936A (es) | 2015-04-15 | 2018-02-01 | Dow Agrosciences Llc | Promotor de plantas para la expresion transgenica. |
CN107624136A (zh) | 2015-04-15 | 2018-01-23 | 美国陶氏益农公司 | 用于转基因表达的植物启动子 |
CN108026149B (zh) | 2015-08-17 | 2022-04-29 | 美国陶氏益农公司 | 工程化的cry6a杀虫蛋白 |
TW201718862A (zh) | 2015-09-22 | 2017-06-01 | Dow Agrosciences Llc | 用於轉殖基因表現之植物啟動子及3’utr |
TW201718861A (zh) | 2015-09-22 | 2017-06-01 | 道禮責任有限公司 | 用於轉殖基因表現之植物啟動子及3’utr |
CN108473997B (zh) | 2015-10-22 | 2022-04-12 | 美国陶氏益农公司 | 用于转基因表达的植物启动子 |
WO2017078935A1 (fr) | 2015-11-04 | 2017-05-11 | Dow Agrosciences Llc | Promoteur végétal pour l'expression d'un transgène |
KR102442450B1 (ko) | 2016-05-12 | 2022-09-14 | 디에스엠 아이피 어셋츠 비.브이. | 미세조류에서 오메가-3 다중불포화 지방산 생산을 증가시키는 방법 |
CA3038972A1 (fr) | 2016-09-30 | 2018-04-05 | Dow Agrosciences Llc | Toxines cry insecticides binaires |
WO2018067264A1 (fr) | 2016-10-03 | 2018-04-12 | Dow Agrosciences Llc | Promoteur de plantes pour l'expression transgénique |
CA3038520A1 (fr) | 2016-10-03 | 2018-04-12 | Dow Agrosciences Llc | Promoteur de plantes pour l'expression transgenique |
US11266174B2 (en) | 2016-10-07 | 2022-03-08 | Altria Client Services Llc | Tobacco plants having increased nitrogen efficiency and methods of using such plants |
CN111527212B (zh) | 2017-08-31 | 2024-04-09 | 科迪华农业科技有限责任公司 | 使用来自叶绿素结合Ab基因的调控元件表达转基因的组合物和方法 |
CN111212562B (zh) | 2017-09-01 | 2023-06-27 | 奥驰亚客户服务有限公司 | 与烟草中提高的氮利用效率有关的方法和组合物 |
CN111630061A (zh) | 2017-12-19 | 2020-09-04 | 先锋国际良种公司 | 杀昆虫多肽及其用途 |
BR102018009263A8 (pt) * | 2018-05-07 | 2023-01-31 | Embrapa Pesquisa Agropecuaria | Molécula de ácido nucleico cry1da códon-otimizada, construção de ácido nucleico, vetor, célula hospedeira, célula vegetal, planta transgênica, método para transformar uma célula, método para produzir uma planta transgênica, método de controle de pragas invertebradas de plantas de cultivo e usos da molécula de ácido nucleico |
WO2019233349A1 (fr) | 2018-06-04 | 2019-12-12 | 青岛清原化合物有限公司 | P-hydroxyphénylpyruvate dioxygénase mutante, et acide nucléique codant et son utilisation |
CA3237962A1 (fr) | 2021-11-09 | 2023-05-19 | Benson Hill, Inc. | Elements de promoteur pour expression de polynucleotide amelioree dans des plantes |
WO2023111961A1 (fr) | 2021-12-15 | 2023-06-22 | Benson Hill, Inc. | Promoteurs spatio-temporels pour l'expression de polynucléotides dans des plantes |
WO2024127362A1 (fr) | 2022-12-15 | 2024-06-20 | Benson Hill, Inc. | Promoteurs spatio-temporels pour l'expression de polynucléotides dans des plantes |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0385962A1 (fr) * | 1989-02-24 | 1990-09-05 | Monsanto Company | Gènes synthétiques de plantes et méthode pour leur préparation |
WO1993007278A1 (fr) * | 1991-10-04 | 1993-04-15 | Ciba-Geigy Ag | Sequence d'adn synthetique ayant une action insecticide accrue dans le mais |
US5380831A (en) * | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0090033A1 (fr) * | 1981-10-01 | 1983-10-05 | International Plant Research Institute | Procede de modification genetique de cereales avec des vecteurs de transformation |
JPS60500795A (ja) * | 1983-01-17 | 1985-05-30 | モンサント カンパニ− | 遺伝子的に形質転換された植物 |
US5034322A (en) * | 1983-01-17 | 1991-07-23 | Monsanto Company | Chimeric genes suitable for expression in plant cells |
DE3484215D1 (de) * | 1983-01-17 | 1991-04-11 | Monsanto Co | Chimaerische gene geeignet zur expression in pflanzenzellen. |
WO1984002919A1 (fr) * | 1983-01-17 | 1984-08-02 | Monsanto Co | Plasmides de transformation de cellules vegetales |
BR8404834A (pt) * | 1983-09-26 | 1985-08-13 | Agrigenetics Res Ass | Metodo para modificar geneticamente uma celula vegetal |
US4889918A (en) * | 1983-12-21 | 1989-12-26 | Boehringer Mannheim Gmbh | Protein tokin from bacillus thiringiensis which is toxic to coleoptera |
DE3346138A1 (de) * | 1983-12-21 | 1985-07-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | Bacillus thuringiensis var. tenebrionis sowie ein insektizid wirkendes, hieraus erhaeltliches praeparat bzw. toxin sowie deren verwendung zur bekaempfung von coleoptera |
US5231019A (en) * | 1984-05-11 | 1993-07-27 | Ciba-Geigy Corporation | Transformation of hereditary material of plants |
CA1301094C (fr) * | 1984-08-31 | 1992-05-19 | Helen Riaboff Whiteley | Segment toxine de proteine cristalline genique de bacillus thuringiensis |
US4945050A (en) * | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
US5036006A (en) * | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
BR8600161A (pt) * | 1985-01-18 | 1986-09-23 | Plant Genetic Systems Nv | Gene quimerico,vetores de plasmidio hibrido,intermediario,processo para controlar insetos em agricultura ou horticultura,composicao inseticida,processo para transformar celulas de plantas para expressar uma toxina de polipeptideo produzida por bacillus thuringiensis,planta,semente de planta,cultura de celulas e plasmidio |
DE3685968T2 (de) * | 1985-01-22 | 1993-07-01 | Mycogen Corp | Zellulare einkapselung biologischer pestizide. |
US4797276A (en) * | 1985-03-22 | 1989-01-10 | Mycogen Corporation | Control of cotton boll weevil, alfalfa weevil, and corn rootworm via contact with a strain of Bacillus thuringiensis |
US4764372A (en) * | 1985-03-22 | 1988-08-16 | Mycogen Corporation | Compositions containing bacillus thuringiensis toxin toxic to beetles of the order coleoptera, and uses thereof |
US5182200A (en) * | 1985-04-22 | 1993-01-26 | Lubrizol Genetics, Inc. | T-dna promoters |
EP0202470B1 (fr) * | 1985-05-20 | 1992-06-03 | Abbott Laboratories | Clonage et expression de gènes de delta-endotoxine de Bacillus thuringiensis en cellules bactériennes et produits obtenus |
EP0206613B1 (fr) * | 1985-06-14 | 1992-08-19 | Repligen Corporation | Delta-endotoxine activée de Bacillus thuringiensis, produit par un gène hybride manipulé |
NZ216723A (en) * | 1985-07-18 | 1988-11-29 | Lubrizol Genetics Inc | Production of insecticidal protein by genetic engineering methods |
US4771131A (en) * | 1985-08-16 | 1988-09-13 | Mycogen Corporation | Cloning and expression of Bacillus thuringiensis toxin gene encoding a protein toxic to beetles of the order Coleoptera |
WO1987006614A1 (fr) * | 1986-04-30 | 1987-11-05 | Boyce Thompson Institute For Plant Research, Inc. | Transformation de l'adn de cellules vegetales et d'organelles a l'aide d'un champ electrique |
TR27832A (tr) * | 1987-04-29 | 1995-08-31 | Monsanto Co | Zararli ucucu hasarata mukavim bitkiler. |
NZ224470A (en) * | 1987-05-05 | 1991-06-25 | Sandoz Ltd | Method of transforming plant cell material; plant cell material and plants |
EP0292435B1 (fr) * | 1987-05-20 | 1995-07-26 | Ciba-Geigy Ag | Plantes de zea mays et plantes transgéniques de zea mays régénérées de protoplastes ou de cellules dérivées de protoplastes |
US4948734A (en) * | 1987-08-12 | 1990-08-14 | Mycogen Corporation | Novel isolates of bacillus thuringiensis having activity against nematodes |
NZ226442A (en) * | 1987-10-13 | 1991-08-27 | Lubrizol Genetics Inc | Anti-coleopteran toxin and gene |
AU2810089A (en) * | 1987-11-19 | 1989-06-14 | Agracetus | Production of proteins in plants |
DE68914477T2 (de) * | 1988-01-22 | 1994-11-24 | Mycogen Corp | Bacillus-thuringiensis-Hybridgen, Plasmid und transformiertes Pseudomonas fluorescens. |
BR8900881A (pt) * | 1988-02-25 | 1989-10-17 | Sandoz Ag | Processos para a producao de uma proteina endotoxina toxica a insetos e composicao inseticida |
US5055294A (en) * | 1988-03-03 | 1991-10-08 | Mycogen Corporation | Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens |
ATE126005T1 (de) * | 1988-04-25 | 1995-08-15 | Monsanto Co | Insektenresistente salatpflanzen. |
ATE120801T1 (de) * | 1988-09-06 | 1995-04-15 | Plant Genetic Systems Nv | Pflanzen, die mit einer lepidopteralen dns- sequenz aus bazillus thuringiensis transformiert werden. |
NZ230375A (en) * | 1988-09-09 | 1991-07-26 | Lubrizol Genetics Inc | Synthetic gene encoding b. thuringiensis insecticidal protein |
EP0382990A1 (fr) * | 1989-02-15 | 1990-08-22 | Plant Genetic Systems, N.V. | Souches de bacillus thuringiensis |
CA2015951A1 (fr) * | 1989-05-18 | 1990-11-18 | Mycogen Corporation | Isolats de bacillus thuringiensis actifs contre la lepidopteres, et gene encodant les nouvelles toxines contre les lepidopteres |
US5141131A (en) * | 1989-06-30 | 1992-08-25 | Dowelanco | Method and apparatus for the acceleration of a propellable matter |
US5177308A (en) * | 1989-11-29 | 1993-01-05 | Agracetus | Insecticidal toxins in plants |
AU649984B2 (en) * | 1989-12-18 | 1994-06-09 | Sandoz Ltd. | Transformation of bacillus thuringiensis and production of a mutant B.t. endotoxin |
US5187091A (en) * | 1990-03-20 | 1993-02-16 | Ecogen Inc. | Bacillus thuringiensis cryiiic gene encoding toxic to coleopteran insects |
TR26973A (tr) * | 1990-04-16 | 1994-09-12 | Ecogen Inc | Bacillus thuringiensis cryie geni ve lepidoptera takimindan böceklere karsi zehirli protein. |
WO1991016432A1 (fr) * | 1990-04-18 | 1991-10-31 | Plant Genetic Systems N.V. | Genes modifies du bacillus thuringiensis codant une proteine cristalline insecticide et leur expression dans des cellules de plantes |
EP0528857B1 (fr) * | 1990-04-26 | 2002-01-30 | Aventis CropScience N.V. | Nouvelle souche de bacillus thuringiensis et sa gene de codage de toxine insecticide |
DK0558676T3 (da) * | 1990-11-23 | 2000-09-25 | Aventis Cropscience Nv | Fremgangsmåde til transformering af enkimbladede planter |
US5384253A (en) * | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
US6294184B1 (en) * | 1991-01-16 | 2001-09-25 | Mycogen Corporation | Process for controlling lepidopteron pests |
US5286485A (en) * | 1991-01-16 | 1994-02-15 | Mycogen Corporation | Process for controlling lepidopteran pests |
US5186934A (en) * | 1991-02-21 | 1993-02-16 | Mycogen Corporation | Bacillus thuringiensis gene encoding a coleopteran-active toxin |
CA2059897A1 (fr) * | 1991-02-25 | 1992-08-26 | Kenneth E. Narva | Genes de bacillus thuringiensis qui codent pour de nouvelles toxines proteiniques contre les coleopteres |
US5262324A (en) * | 1991-11-06 | 1993-11-16 | Mycogen Corporation | Coleopteran-active Bacillus thuringiensis isolates and genes encoding coleopteran-active toxins |
WO1993021335A2 (fr) * | 1992-04-15 | 1993-10-28 | Plant Genetic Systems, N.V. | Transformation de cellules de plantes monocotyledones |
EP0582541A3 (fr) * | 1992-05-01 | 1995-04-19 | Sandoz Ltd | Procédé pour la création de souches de Bacillus thuringiensis capables de conjugaison. |
US5262159A (en) * | 1992-08-24 | 1993-11-16 | Mycogen Corporation | Use of Bacillus thuringiensis isolates for controlling pests in the family aphididae |
-
1996
- 1996-10-11 BR BR9611000-7A patent/BR9611000A/pt not_active IP Right Cessation
- 1996-10-11 RU RU98111460/13A patent/RU2224795C2/ru not_active IP Right Cessation
- 1996-10-11 AU AU74467/96A patent/AU708256B2/en not_active Ceased
- 1996-10-11 WO PCT/US1996/016582 patent/WO1997013402A1/fr active Application Filing
- 1996-10-11 US US08/729,601 patent/US6166302A/en not_active Expired - Lifetime
- 1996-10-11 EP EP96936576A patent/EP0861021B1/fr not_active Expired - Lifetime
- 1996-10-11 DE DE69638032T patent/DE69638032D1/de not_active Expired - Lifetime
- 1996-10-11 AT AT96936576T patent/ATE443437T1/de not_active IP Right Cessation
- 1996-10-11 IL IL12402096A patent/IL124020A/xx not_active IP Right Cessation
- 1996-10-11 CN CNB961975873A patent/CN1176577C/zh not_active Expired - Fee Related
- 1996-10-11 CA CA002234656A patent/CA2234656C/fr not_active Expired - Fee Related
- 1996-10-11 ES ES96936576T patent/ES2330168T3/es not_active Expired - Lifetime
- 1996-10-11 JP JP51530097A patent/JP4030582B2/ja not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5380831A (en) * | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
EP0385962A1 (fr) * | 1989-02-24 | 1990-09-05 | Monsanto Company | Gènes synthétiques de plantes et méthode pour leur préparation |
WO1993007278A1 (fr) * | 1991-10-04 | 1993-04-15 | Ciba-Geigy Ag | Sequence d'adn synthetique ayant une action insecticide accrue dans le mais |
Non-Patent Citations (1)
Title |
---|
See also references of WO9713402A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU7446796A (en) | 1997-04-30 |
AU708256B2 (en) | 1999-07-29 |
CN1176577C (zh) | 2004-11-24 |
EP0861021B1 (fr) | 2009-09-23 |
ES2330168T3 (es) | 2009-12-04 |
IL124020A (en) | 2003-05-29 |
JP4030582B2 (ja) | 2008-01-09 |
MX9802778A (es) | 1998-10-31 |
JP2000507808A (ja) | 2000-06-27 |
CA2234656A1 (fr) | 1997-04-17 |
BR9611000A (pt) | 1999-12-28 |
ATE443437T1 (de) | 2009-10-15 |
CN1199321A (zh) | 1998-11-18 |
EP0861021A4 (fr) | 2005-01-12 |
DE69638032D1 (de) | 2009-11-05 |
US6166302A (en) | 2000-12-26 |
CA2234656C (fr) | 2008-01-08 |
RU2224795C2 (ru) | 2004-02-27 |
WO1997013402A1 (fr) | 1997-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0861021B1 (fr) | Gene modifie de bacillus thuringiensis pour combattre les lepidopteres sur les plantes | |
US5608142A (en) | Insecticidal cotton plants | |
Murray et al. | Analysis of unstable RNA transcripts of insecticidal crystal protein genes of Bacillus thuringiensis in transgenic plants and electroporated protoplasts | |
EP0340197B1 (fr) | Plantes de laitue résistantes aux insectes | |
EP1127125B1 (fr) | Procedes servant a transformer des plantes pour exprimer les delta-endotoxines du bacille thuringiensis | |
EP0358557B1 (fr) | Plantes transformées par une séquence d'ADN, lethale pour les lepidoptera, de bacillus thuringiensis | |
JP2002176995A (ja) | 殺虫性結晶タンパクの合成遺伝子 | |
CA2339641C (fr) | Elements de regulation de traduction pour expression de proteine de niveau eleve dans les plastes de plantes superieures et leurs procedes d'utilisation | |
US7504555B2 (en) | Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof | |
CN113195723A (zh) | 密码子优化的cry1Da核酸分子、核酸构建体、载体、宿主细胞、植物细胞、转基因植物、转化细胞的方法、生产转基因植物的方法、控制作物植物中的无脊椎害虫的方法和该核酸分子的用途 | |
US5850018A (en) | Expression control sequence for general and effective expression of genes in plants | |
US6706860B2 (en) | Toxins | |
CN110923214B (zh) | 抗病转TaM2K基因小麦的培育方法及其相关生物材料 | |
JP5054267B2 (ja) | 新規トキシン | |
WO1989004868A1 (fr) | Production de proteines dans des plantes | |
US20040221333A1 (en) | Novel toxins | |
AU5424499A (en) | Modified synthetic dna sequences for improved insecticidal control | |
MXPA98002778A (en) | Gene of bacillus thuringiensis modified for control of lepidopteros in plan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980422 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20041129 |
|
17Q | First examination report despatched |
Effective date: 20050810 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 69638032 Country of ref document: DE Date of ref document: 20091105 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2330168 Country of ref document: ES Kind code of ref document: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091031 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20090923 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20091223 |
|
26N | No opposition filed |
Effective date: 20100624 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091031 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091011 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091224 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091223 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091011 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20140911 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20141007 Year of fee payment: 19 Ref country code: FR Payment date: 20141008 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20141021 Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 69638032 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151011 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160503 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20160630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151102 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20161125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151012 |